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ABSTRACT 
The number of older persons and individuals with cognitive impairment is 
expected to increase dramatically in most parts of the world. It is therefore 
important to learn more about disorders that affect cognition. Idiopathic 
normal pressure hydrocephalus (iNPH) mainly occurs in older persons and 
symptoms include cognitive impairment, gait disturbance and urinary 
symptoms. The aim of this thesis was to examine various aspects regarding 
the epidemiology of iNPH.  
The sample comprised data from the Gothenburg population studies. Study 
participants underwent comprehensive clinical and neuropsychiatric 
examinations between 1986 and 2009. iNPH was diagnosed in concordance 
with criteria from international consensus guidelines.  
Study I: The prevalence of iNPH was higher than previously reported. More 
than one in twenty, among 80-year-olds, had signs and symptoms consistent 
with probable iNPH. Study II: Vascular risk factors and markers of 
cerebrovascular disease were associated with iNPH. Hypertension was 
related to an almost three-fold increased chance of having imaging signs of 
iNPH. For diabetes, it was more than four-fold. The strongest relation to iNPH 
was for cerebral white matter lesions, which were associated with a more 
than six-fold increased chance. Study III: More than one fifth of the sample 
had ventricular enlargement, defined by current cut-off values for Evans 
Index. In addition, men aged 80 years or more, had on average, values equal 
to or higher than what is currently considered pathological. Study IV: Persons 
who fulfilled criteria for probable iNPH had an almost four-fold increased risk 
of death. In those with radiological signs of iNPH, the risk of dementia was 
almost three-fold increased.  
iNPH is probably more common than previously supposed. Many older 
persons have clinical and imaging signs consistent with iNPH. These findings 
are important considering that iNPH is a treatable disorder. Vascular factors 
are probably involved in the pathophysiology. Current cut-off values for 
ventricular enlargement, using Evans Index, ought to be reappraised in order 
to improve diagnostic possibilities. Untreated iNPH is associated with a poor 
prognosis with a high risk of death or dementia. Radiological signs of iNPH 
may have a greater prognostic importance than previously presumed.  
ISBN: 978-91-628-9784-0 (Print)  
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SAMMANFATTNING PÅ SVENSKA 
Antalet äldre och personer med nedsatt kognitiv förmåga förväntas öka 
dramatiskt de kommande åren. Det är således av stor vikt att studera 
sjukdomar som påverkar intellektuella funktioner. Idiopatisk 
normaltryckshydrocefalus (iNPH) drabbar framförallt äldre personer. 
Symptomen innefattar försämrad kognitiv funktion, gångsvårigheter och 
vattenkastningsbesvär. Syftet med denna avhandling var att undersöka 
epidemiologiska aspekter av denna sjukdom. 
Materialet utgörs av ett befolkningsmaterial från populationsstudierna i 
Göteborg. Studiedeltagare genomgick omfattande undersökningar, inklusive 
datortomografi av hjärnan, mellan åren 1986 och 2009.  
Delstudie I: Förekomsten av iNPH var högre än vad man tidigare uppskattat. 
Mer än var tjugonde 80-åring uppvisade kliniska och radiologiska fynd 
förenliga med iNPH. Delstudie II: Vaskulära riskfaktorer och markörer för 
cerebrovaskulär sjukdom var kopplat till iNPH. Hypertoni ökade 
sannolikheten att ha radiologiska fynd förenliga med iNPH nästan trefaldigt. 
Gällande diabetes var sannolikheten mer än fyrfaldigt ökad. Starkast koppling 
var till vitsubstansförändringar som gav en mer än sexfaldigt ökad 
sannolikhet. Delstudie III: Mer än en femtedel av alla hade förstorade 
ventriklar enligt gällande definition, baserat på Evans Index. Dessutom hade 
män, i åldrarna 80 år och äldre, i genomsnitt ett värde på Evans Index som 
utifrån dagens kriterier skulle klassas som sjukligt. Delstudie IV: De som 
uppfyllde kriterierna för iNPH hade en nästan fyrfaldigt ökad risk för död. 
Dessutom var risken för demens nästan trefaldigt ökad hos de som hade 
radiologiska fynd förenliga med iNPH. 
Många äldre har kliniska och radiologiska fynd förenliga med iNPH, vilket 
talar för att diagnosen är betydligt vanligare än vad man tidigare har trott. 
Dessa resultat kan vara av betydelse med tanke på att sjukdomen är 
behandlingsbar. Vidare pekar den höga förekomsten av kärlsjukdomar mot 
att cerebrovaskulära förändringar är involverade i sjukdomsmekanismen. För 
att förbättra diagnostiken bör nuvarande kriterier för ventrikelvidgning, 
baserat på Evans Index, ses över. Vidare, förefaller obehandlad iNPH vara 
kopplat till en dålig prognos med ökad risk för demens och tidig död. 
Slutligen, radiologiska fynd verkar vara av större prognostisk betydelse än 
vad man tidigare har trott.  
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Hydrocephalus –  
 
From the Greek words  
“Hydor”= water and “Kéfale”= skull 
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1 NORMAL PRESSURE 
HYDROCEPHALUS - AN INTRODUCTION 
 
Classification of Hydrocephalus 
Hydrocephalus is a term for various conditions characterized by impaired 
cerebrospinal fluid (CSF) dynamics. Enlargement of the cerebral ventricles is 
one of the main hallmarks.1 Hydrocephalus includes several different 
disorders with varying causes and clinical presentations, and can therefore 
occur in all ages.2 The topic of this thesis is idiopathic normal pressure 
hydrocephalus, which is an adult form.  
The classification of the hydrocephalic disorders is largely based on the 
anatomy and physiology of the central nervous system (figure 1). 
Hydrocephalus can be classified into two main forms: non-communicating 
(obstructive) hydrocephalus, and communicating (non-obstructive) 
hydrocephalus. Non-communicating hydrocephalus is characterized by an 
obstruction of the CSF flow, somewhere between the point of production and 
absorption. Causes can include congenital malformations, hemorrhage, 
tumors and various other intracranial mass lesions. Non-communicating 
hydrocephalus can affect persons of all ages and have an acute or chronic 
onset. Clinical features depend on the underlying cause.2 Because CSF flow 
is obstructed, intracranial pressure (ICP) can be increased. In contrast, in the 
communicating form of hydrocephalus, there are no visible obstructions of 
CSF flow, and the underlying mechanisms are not fully understood. There is 
no increase in intracranial pressure, hence the name normal pressure 
hydrocephalus (NPH).3 NPH affects adults, and is further divided into two 
groups. When it is caused by certain precipitants, such as trauma, meningitis 
or subarachnoid hemorrhage, NPH is classified as secondary (sNPH). In 
cases where no identifiable cause can be found, NPH is labeled idiopathic 
(iNPH).3, 4 This thesis involves iNPH and discussions regarding other forms of 
hydrocephalus are beyond the scope of the present work. 
Epidemiology of Normal Pressure Hydrocephalus 
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Figure 1. Classification of hydrocephalus. 
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In order to fully understand the present, we must first have knowledge about the past. 
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History of iNPH 
The first modern description of iNPH was made by the Colombian 
neurosurgeon Salomón Hakim in 1965.5, 6 In the original publications, two 
cases of secondary NPH, following traumatic brain injury, and one case of 
idiopathic NPH were described. The patients presented with cognitive 
impairment, gait disturbance and urinary incontinence and were noted to 
have distended ventricles on angiography and pneumoencephalogram. 
Lumbar puncture was performed and intracranial pressure was found to be 
within normal limits. Interestingly, after the lumbar puncture, clinical 
improvement was noted. Shunt surgery was performed and further 
improvement occurred.  
After having published his original finding, Salomón Hakim devoted himself to 
further research on NPH and its potential causes. In particular, he was 
interested in intracranial biomechanics. Thus, he spent much time on the 
hydrodynamic aspects of CSF and the cerebral ventricles.7 He theorized that, 
because pressure is defined as force per unit area, the ventricles in NPH 
could be enlarged due to increased force acting on the brain tissue while the 
CSF pressure remains constant.  
Although, neither change in intracranial pressure nor ventricle size have 
subsequently been found to relate to postoperative improvement, much of the 
research has so far been focused on pressure-volume relationships. 
However, it might be that the complexities involved in the CSF circulation 
have been underestimated. Also, compared to the hydrodynamic aspects, 
other research areas in iNPH, such as the overlap between other 
neurodegenerative disorders have thus far received less attention. 
Clinical Features  
iNPH mainly affects older persons and symptoms often develop insidiously. 
Core signs and symptoms include gait and balance disturbance, cognitive 
impairment and urinary symptoms.1 These are summarized in figure 2. The 
symptoms are sometimes referred to as the “typical triad”. However, this is 
Daniel Jaraj 
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probably not an appropriate description for several reasons. Approximately 
half of all patients might only have one or two of these symptoms.8 Thus, the 
constellation of clinical characteristics is likely more complex than implied by 
the term “triad”. Furthermore, there is uncertainty regarding the exact 
distinctive features for each symptom. Gait and balance problems, cognitive 
dysfunction and urinary symptoms are common in older persons and may 
sometimes be due comorbidities.9, 10 Therefore, ascribing these symptoms to 
patients with suspicions of iNPH should be made in a thoughtful manner.  
Gait and Balance   
Gait disturbance is common in iNPH. It is often stated to be the first symptom 
to develop, and the most characteristic. However, it is not known whether this 
is truly the case. For example, it might be that walking difficulties are more 
easily detected at an initial stage than subtle cognitive symptoms. 
Nevertheless, gait disturbance is an important part of the clinical picture. 
Typically the abnormal gait pattern is characterized as broad-based, 
magnetic with reduced cadence, step height and step width.11, 12 In classic 
literature, the gait is sometimes described as apraxic. Sometimes the gait 
pattern can have features of Parkinsonism, such as hesitation, freezing and 
reduced arm-swing. However, iNPH-patients more typically have retropulsion, 
i.e. a tendency towards a backward-extended posture.13  
Epidemiology of Normal Pressure Hydrocephalus 
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Figure 2.  
 
The balance and posture dysfunction seems to be related to a backward-
displaced center of pressure and a defective vertical visual perception.14 
Other characteristics of the gait pattern include outward rotation of the feet, 
and difficulties turning.11 Impaired balance often coexists with gait 
disturbance in iNPH, and can result in an increased risk of falls. Although the 
mechanisms underlying gait and balance disturbance in iNPH are not 
precisely known, these symptoms may be similar to those seen in patients 
with vascular cognitive impairment.15 
Cognitive impairment 
Symptoms and signs of cognitive impairment are common among patients 
with iNPH. Often cognitive impairment in iNPH is of the frontal-subcortical 
type. Thus, common features include psychomotor slowing, inattention, 
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forgetfulness and impaired executive functions.1, 16 In a study comparing 
iNPH with patients with Alzheimer’s disease, those with iNPH had more 
frontal lobe symptoms.17 They were found to have a more pronounced 
impairment regarding attention and psychomotor speed, whereas the patients 
with Alzheimer’s disease had worse memory. It was speculated that the 
frontal lobe symptoms in iNPH might be secondary to subcortical, 
periventricular, white matter disease. In another study, compared to healthy 
individuals, iNPH patients had impaired functions in several domains, as 
described above, and also exhibited signs of impaired dexterity and fine 
motor skills.18 It was also found that neuropsychological impairment was 
associated with gait disturbance, incontinence and increased daily sleep.18 
iNPH patients with concomitant vascular risk factors performed worse on 
neuropsychological tests. Several of these findings were later confirmed in a 
rather large, multicenter study.19 The authors speculate that the signs and 
symptoms in iNPH might be due to multifocal periventricular hypometabolism 
in combination with impaired connectivity in cortical-subcortical circuits. It was 
also theorized that the reduced wakefulness might be caused by dysfunction 
in the ascending activating systems.  
Urinary Symptoms 
Urinary symptoms are common in iNPH. It is said that patients often 
experience increased frequency and urgency early on, and develop 
incontinence at later stages.1 However, urinary symptoms are very common 
in both men and women in the general population. Thus, it can be difficult to 
differentiate these symptoms of iNPH from other causes. Urgency and 
incontinence in iNPH is thought to occur from a central disinhibition leading to 
hyperactivity of the detrusor, as this has been found in urodynamic studies.20, 
21 Impaired cognition and locomotion may however also contribute.   
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Anatomy and Physiology of the CSF Circulation 
CSF (Liquor cerebrospinalis) is a clear and colorless fluid that surrounds the 
central nervous system. CSF has several vital physiological functions, such 
as protective cushioning, regulation of intracranial pressure and transport of 
metabolites and waste products.22 The total volume of CSF (surrounding the 
brain and spinal cord) is approximately 200 ml. Turnover is rather high given 
that the production rate is around 500 ml per day (20 ml per hour).23 Thus, 
daily formation is two to three times higher than the total CSF volume. The 
basic anatomy of the ventricular system is shown in figure 3.  
The arachnocentric view on CSF circulation 
The traditional approach to CSF circulation is largely based on anatomical 
descriptions and experiments made in the nineteenth century and beginning 
of twentieth century, i.e. more than 100-150 years ago.24 Much emphasis has 
been placed on the absorptive pathways through the arachnoid villi. 
Therefore, the traditional view on CSF circulation could be said to have an 
arachnocentric focus. Accordingly, the main production site of CSF is the 
choroid plexus.25 CSF flows in a pulsatile manner with each cardiac cycle. A 
net flow occurs from the lateral ventricles, through the foramina of Monro to 
the third ventricle, from there, through the aqueduct of Sylvius down to the 
fourth ventricle and eventually exits through foramen of Magendie and 
Luschkae. The CSF enters the subarachnoid space of the cisterna magna. 
Traditionally CSF is said to travel down the subarachnoid space of the spinal 
cord and also directly up along the cerebral convexities where it is absorbed 
into the venous blood of sinuses through the arachnoid granulations.  
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Figure 3. Schematic illustration of the cerebral ventricles and outflow tracts 
 
A more contemporary approach to CSF dynamics 
The traditional view on CSF circulation is rather straightforward and easy to 
grasp. However, recent findings indicate a more complex process, and there 
is now increasing evidence that the traditional view on CSF circulation is 
over-simplified and outdated. For example, the brain parenchyma, capillaries 
including perivascular spaces and interstitial fluid might be more important for 
CSF production and absorption than the choroid plexus and arachnoid 
granulations.22, 26, 27 In upright active individuals up to two thirds of CSF 
absorption can occur through the spinal subarachnoid space.28 Furthermore, 
perineural sheaths of pia and arachnoid mater along cranial- and spinal 
nerves have been found to constitute important pathways of lymphatic CSF 
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drainageA. 29 Several studies have shown that CSF tracers readily enter 
extra-cranial lymphatics, such as the cervical lymph nodes, and ultimately the 
blood stream. In one study performed on sheep, the cribriform plate was 
obstructed, blocking absorption to the nasal mucosa lymphatics.30 This led to 
an increased intracranial pressure and an almost three-fold increase in CSF 
outflow resistance.  
To complicate things further…  
In 2013, a landmark paper was published in Science that provided a possible 
explanation for the function of sleep. 31 As it turns out, the findings may also 
have implications for our understanding of the CSF circulation, and possibly 
the pathophysiology of iNPH.  
Real-time imaging was made, in vivo, using fluorescent tracers, injected into 
the CSF. This was performed in asleep and awake mice and in anesthetized 
mice. Intriguingly, in the sleeping and anesthetized mice, a substantial influx 
of CSF occurred along the para-arterial spaces into the brain parenchyma. 
Upon arousal, however, this influx decreased by approximately 95 %. This 
was then repeated using radiolabeled amyloid beta (Aβ). It was found that 
during sleep, Aβ was cleared from the interstitial space two-times faster than 
during the awake state. Furthermore, cortical interstitial volume was also 
measured and found to increase almost twofold during sleep.   
These findings indicate that during sleep, the interstitial volume shrinks. This 
in turn, allows influx of CSF along the para-arterial spaces, and clearance of 
metabolites and waste products. The pathway of waste clearance, from the 
extracellular space, occurred as a convective flow through a complex 
astroglial network referred to as the glymphatic system.  
                                                      
A The lymphatic system has an important role in the clearance of metabolic waste. In 
almost all organs, the number of lymphatic pathways is proportional to the metabolic 
activity. The brain is however an exception. It is interesting that despite having the 
highest metabolic activity, and thus an enormous need for waste clearance, the CNS 
itself lacks lymphatic vessels.    
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These processes are believed to require a high energy expenditure, which 
cannot be accommodated in the aroused state. While awake, the brain has to 
take in, filter, and process vast amounts of new data. Therefore, maintenance 
and household functions in the brain, i.e. elimination of waste, takes place 
during sleep.  
The glymphatic system is composed of three main parts, a para-arterial influx 
of CSF from the subarachnoid space, a trans-parenchymal passage route 
through an astroglial system, where the CSF mixes with interstitial fluid, and 
finally a para-venous clearance route. The process is mediated by aquaporin 
4 (AQP4) channels located on the endfeet of the astrocytes (Figure 4). 
It is believed that the glymphatic system can be disrupted by vascular injury 
and traumatic brain injury. This could lead to reactive astrogliosis with 
resulting displacement of the AQP4 channels.32, 33 As the glymphatic system 
fails, clearance of waste products decrease and potentially neuro-toxic 
proteins, such as Tau and amyloid may accumulate ultimately leading to 
further brain injury and neurodegeneration. In the context of iNPH, it is 
interesting that decreased wakefulness is a frequently occurring symptom 
among patients. Also, AQP4 seem to be involved in regulation of brain water 
content, and levels of AQP4 have been found to be altered in 
hydrocephalus.34 
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Figure 4. The Glymphatic system (The figure is a simplified representation. In 
actuality, the end-feed of astrocytes cover almost the entire capillary surface) 
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Pathophysiology  
It is often believed that iNPH is primarily caused by an alteration of CSF 
dynamics, such as decreased absorption.35 This might very well be true. 
However, there is so far little evidence that directly supports this notion. 
Indeed CSF diversion does improve symptoms. Though, it is theoretically 
possible that the effect of shunt surgery is due to secondary changes in the 
cerebral microcirculation.  It might be that the previously oversimplified 
concepts of CSF circulation have led to an underestimation of the actual 
complexities involved in the pathophysiology. 
Morphological changes of CSF outflow tracts, such as arachnoid fibrosis 
have been noted in some patients on autopsy.36 This might implicate an 
impaired outflow as a pathological basis. However, most studies included 
only a few cases, and more recent papers have provided contradictory 
results.37 Also, patients with iNPH are said to have an increased resistance to 
CSF outflow.38 However, most patients with iNPH are older, and it is known 
that both production and absorption of CSF decreases with age.39, 40 
Furthermore, values of CSF outflow resistance (Rout) that are considered 
pathological may be found in as many as 25 % of healthy elderly.41 Moreover, 
other measures of CSF dynamics, such as continuous monitoring of 
intracranial pressure and radionuclide cisternography, that are often said to 
show characteristic features of iNPH, lack evidence-based support.42 For 
example, intermittent alterations of intracranial pressure have been reported 
to be diagnostic of iNPH and useful as a prognostic marker in terms of shunt 
surgery.43, 44 however, similar findings are seen in healthy individuals and 
might actually be physiological occurrences.28, 45 Thus, regarding the 
pathophysiology, mechanisms other than those involving CSF dynamics 
should also be considered. 
The role of vascular disease  
There are numerous reports linking iNPH to various vascular risk factors 
including hypertension, diabetes mellitus and heart disease.46-50 These 
studies were made using hospital-based samples. Thus population-based 
epidemiological studies have so far been lacking. Also, in a review issued by 
Epidemiology of Normal Pressure Hydrocephalus 
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a task force for the International Society for Hydrocephalus and 
Cerebrospinal Fluid Disorders (ISHCSF), it was noted that the previous 
studies were based on small samples and were more than twenty years old.10 
Furthermore, these papers do not provide data for a direct causal relation. 
Nevertheless, a possible causal association between vascular disease 
processes and iNPH is further supported by several additional studies. 
Arterial hypertension is more common in patients with iNPH, and a previous 
prospective cohort study found that systolic blood pressure and pulse 
pressure were related to development of increased ventricle size.51 
Interestingly, the relation between hypertension and ventricular enlargement 
is also supported by animal studies. Spontaneously hypertensive rats have 
been found to develop enlarged ventricles.52 In addition, another study on 
sheep found that hydrocephalus developed quickly after that balloons were 
inserted into the ventricles and set to inflate during systole and deflate during 
diastole, thereby increasing the pulse pressure.53  
Small vessel disease has also been implicated in the pathogenesis of iNPH. 
Neuropathological examinations have revealed signs of cerebrovascular 
disease in patients with iNPH.54 In addition, cerebral white matter lesions 
(WMLs), which are associated with small vessel disease and white matter 
ischemia 55, have been found to be more common in iNPH compared to 
controls.56, 57 Furthermore, WMLs are related to similar subcortical symptoms, 
such as gait disturbance, urinary incontinence and cognitive impairment.58 
Moreover, WMLs have been found to decrease after shunt surgery, with 
reductions correlating with clinical improvement.59, 60 Additional support for a 
vascular pathology underlying iNPH comes from numerous studies that have 
found reduced blood flow in several areas including the periventricular white 
matter.61-63 Also, cerebral blood flow has been found to increase after CSF 
removal via lumbar puncture or shunt surgery.64, 65  
Some authors have reported that WMLs in iNPH might be associated with a 
poor response to shunt surgery.66 However, this may be contradicted by a 
randomized, double-blinded sham-controlled study that included iNPH 
patients with severe white matter disease, who also fulfilled criteria for 
Daniel Jaraj 
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Binswanger’s disease.67 Half of the patients received a standard 
ventriculoperitoneal shunt, and half received a ligated shunt. After three 
months, the patients in the treatment group improved while no improvement 
was noted in the control group. After the three months, the ligated shunts 
were opened in the control patients, after which they to improved.  
Further support for a vascular disease mechanism might come from a recent 
study in which iNPH patients were found to have a higher number of cerebral 
microbleeds than healthy controls.68 The association between iNPH and 
cerebral microbleeds might be due to small vessel disease.    
Two studies have reported interesting results regarding the reduction of white 
matter hyperintensities and clinical improvement in iNPH patients treated with 
Acetazolamide.69, 70 Acetazolamide, a carbonic anhydrase inhibitor, is the 
only potential pharmacological treatment that has been proposed for iNPH. It 
is currently approved for treatment of glaucoma, idiopathic intracranial 
hypertension and acute mountain sickness. Acetazolamide is a diuretic and 
has been shown to reduce CSF production. More importantly, Acetazolamide 
is also a vasodilator that has been shown to increase cerebral blood flow.71, 72 
Among eight, non-shunted, iNPH patients treated with Acetazolamide, five 
responded positively with improved gait.69 Furthermore, a significant 
reduction in periventricular hyperintensities was seen. In another study, non-
shunted iNPH patients, treated with Acetazolamide underwent repeated MRI 
and clinical assessments.70 These were compared to iNPH patients who 
underwent external lumbar drainage (ELD) and controls consisting of iNPH 
patients without intervention. White matter changes decreased in those 
treated with Acetazolamide and in the patients who underwent ELD, but not 
among controls. It is important to note that WMLs in iNPH might have other 
causes than ischemia, such edema or CSF stagnation, and the authors state 
the positive effects of Acetazolamide might be due to decreased interstitial 
brain water, reduced transependymal CSF flow, or increased cerebral blood 
flow. Regardless, the findings of these studies are highly intriguingB, and a 
                                                      
B Of interest, Acetazolamide has also been suggested to be a blocker of aquaporin 
channels (Owler et al. Cerebrospinal Fluid Research 2010, 7:15)  
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randomized controlled trial on Acetazolamide in iNPH would probably be of 
value. 
As mentioned in the previous section, it is conceivable that vascular 
disturbances and ischemia might contribute to partially reversible changes in 
the microcirculation. However, the exact mechanisms linking vascular 
disease to iNPH are currently not clear.  
Other potential causes 
Interestingly, iNPH patients have been found to have larger head size than 
healthy controls.73, 74 This might suggest that iNPH is a congenital disorder 
that becomes symptomatic in late life. Given these findings, it has been 
hypothesized iNPH might be a “two-hit disease”.75, 76 Accordingly it was 
theorized that iNPH begins with benign external hydrocephalus during infancy 
(the first hit), which causes an increased head size and ventricle size. After 
this, the person may be asymptomatic until late-life, when white matter 
disease develops (the second hit). The authors state that white matter 
ischemia, with resulting myelin loss, may give rise to a more hydrophilic 
environment that impedes CSF flow through the extracellular space. This 
process ultimately leads to further decrease of CSF absorption with clinical 
decompensation causing the person to become symptomatic.  
However, another study found that head circumference was only increased in 
a subset of iNPH patients.77 The authors found that the number of patients 
with iNPH who had a head circumference above the 90th percentile was 
significantly increased compared to controls. Though, this was not the case 
for the rest of the iNPH sample. The distribution among those with a head 
circumference below the 90th percentile was similar to that of the control 
population. These results imply that a congenital cause of iNPH might be the 
case only in a minority of the patients. Of further importance, it has been 
suggested that iNPH, in fact is a rather heterogeneous syndrome with many 
potential causes and that persons with suspected iNPH might also have other 
neurodegenerative disorders or various concomitant comorbidities.10, 78 This 
might be true, at least to some extent, given the considerable overlap 
between iNPH and other neurodegenerative diseases.  
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Cerebral amyloid pathology in iNPH and overlapping features with 
Alzheimer’s disease 
iNPH and Alzheimer’s disease have several common features. These include 
clinical, radiological and biochemical findings. For example, patients with 
Alzheimer’s disease often have enlarged ventricles, gait disturbance and 
urinary problems. Also, patients with iNPH have reduced levels of Amyloid- β 
(Aβ42) in CSF, similar to those with Alzheimer’s disease.79 In addition, 
Amyloid-β is frequently found in cortical brain biopsies in iNPH.80 In fact the 
two diseases are thought to often coexist. Some authors have therefore 
hypothesized that iNPH and Alzheimer’s disease might have a common 
etiological mechanism.81 It was previously postulated that both diseases are 
the result of hydrodynamic disturbances of CSF flow. Alzheimer’s disease 
was theorized to be due reduced CSF production, with decreased turnover of 
CSF ultimately leading to accumulation of Aβ42 and in turn causing 
neurodegeneration. iNPH, on the other hand was thought to occur from a 
decreased CSF absorption which would also lead to decreased turnover of 
CSF and accumulation of Aβ42 giving rise to a similar syndrome as 
Alzheimer’s disease. Based on this, a pilot study was conducted in order to 
examine the possible therapeutic effects of shunt surgery in patients with 
Alzheimer’s disease.82 However, despite initially promising results, a 
randomized, double-blinded, sham-controlled trial later showed no benefit of 
CSF shunting in patients with Alzheimer’s disease.83  
There might also be other explanations for the existence of cerebral amyloid 
pathology in iNPH. It might be that the development of iNPH is related to 
interstitial CSF stagnation with reduced periventricular metabolism leading to 
decreased CSF clearance and accumulation of Aβ42. A study conducted in 
Gothenburg, Sweden found that patients with iNPH, compared to healthy 
individuals, had not only low levels of Aβ42 but also other types of amyloid 
proteins (Aβ38, Aβ40, sAPPα and sAPPβ) were low.84 This finding is typically 
not seen in Alzheimer’s disease. The authors found also increased levels of 
neurofilament light protein (NFL), which might be due to degeneration of 
periventricular axons. Moreover, all amyloid proteins increased in ventricle 
CSF after shunt surgery. It has, since then, been theorized that that the low 
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levels of CSF Aβ42, in iNPH, are not due to deposition (as in Alzheimer’s 
disease) but instead caused by decreased clearance via the glymphatic 
system.85  
In a study from Finland, cortical biopsies were obtained, during shunt surgery 
or postmortem, from patients with iNPH and Alzheimer’s disease.86 iNPH 
patients with amyloid pathology had higher levels of γ-secretase activity 
compared to iNPH patients without amyloid pathology. Patients with 
Alzheimer’s disease, on the other hand, are known to have increased activity 
of β-secretase. These findings might indicate different pathophysiological 
mechanisms. In addition, in a relatively large cohort of iNPH patients from the 
same registry, no association was found between Apolipoprotein E-status 
and iNPH.87 Furthermore, patients with iNPH seem to have larger 
hippocampus volumes than those with Alzheimer’s disease.88 Another study 
is also worth mentioning. Positron emission tomography (PET) imaging was 
made, using 11C-labeled radiotracer Pittsburgh compound B imaging (PIB) to 
detect cerebral amyloid pathology and compare patients with iNPH and those 
with Alzheimer’s disease.89 Three out of ten iNPH patients had increased 
cortical amyloid. However, the amyloid distribution was different in those with 
iNPH compared to those with Alzheimer’s disease. Those with Alzheimer’s 
disease showed increased levels in the frontal and temporoparietal areas, 
while those with iNPH had a distribution limited to the high convexity and 
parasagittal areas. The authors state that these regions might be 
mechanically more compressed in iNPH, resulting in decreased clearance of 
Amyloid-β. 
Although both patients with iNPH and Alzheimer’s disease may have cerebral 
amyloid pathology, altogether, previous results suggest that the 
pathophysiological mechanisms are different. Nevertheless, many of the 
common features are interesting and perhaps worthy of further investigation.   
Why are the ventricles enlarged? 
In obstructive hydrocephalus intracranial pressure (ICP) is increased and the 
reason for ventricular enlargement could be regarded as rather intuitive. 
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However, in iNPH ICP appears to be within normal range and the cause of 
ventricular enlargement has puzzled the scientific community for decades.  
Originally it was postulated that an increase in ventricle size might result in a 
concomitant decrease in pressure.7 This reasoning was partly based on 
Pascal’s principle, in which pressure is equal to force per unit area. Thus ICP 
could be normal due to having an increased area (ventricle volume) and 
increased force acting on the ventricle walls. Owing to this, it has been 
theorized that iNPH might be due to microscopic obstructions of CSF flow 
such as scarring or fibrosis of the arachnoid granulations. However, 
histopathological studies have been unable to confirm this.37 Furthermore, 
attempts to predict response to shunt surgery based on pressure-volume 
variables have been futile. Some patients have normal resistance to CSF 
outflow, but improve after CSF diversion while others have elevated outflow 
resistance but remain unchanged.90 These findings are difficult to explain 
using the previous models. Therefore, the exact reason for ventricular 
enlargement remains highly unclear.  
It is well known that patients with cerebral atrophy can have enlarged 
ventricles (a condition sometimes termed hydrocephalus ex vacuo). However, 
not all patients with brain atrophy have enlarged ventricles. Therefore, it is 
theoretically possible that ventricular enlargement in some patients with 
Alzheimer’s disease and vascular dementia is not entirely attributable to loss 
of brain parenchyma. For instance, it might be that there are concurrent 
changes in the cerebral microcirculation similar to that in iNPH. This could 
possibly also explain part of the overlap regarding symptoms. However, other 
typical radiological signs of iNPH such as narrowing of high convexity sulci 
and subarachnoid space do not seem to be common in other 
neurodegenerative disorders. Although, this has, so far, not been 
investigated using population samples. 
As mentioned earlier, hypertension and diabetes are common in iNPH. It 
might also be that stiffening of large vessels, due to atherosclerotic 
processes, lead to an increased pulse-pressure. This could, in turn, result in 
increased mechanical force acting on the brain parenchyma leading to 
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ventricular enlargement. However, in order to gain knowledge on this topic, 
epidemiological studies using population-based samples with longitudinal 
data are needed. For example, the order of events regarding development of 
different radiological signs and clinical features are currently not known.  
Prevalence and Incidence 
Epidemiological studies in iNPH are scarce and there are few population 
studies on the prevalence and incidence. Most previous studies were made 
using smaller samples and included few people above age 80 years. Also, 
several authors have stated that iNPH is a rare disorder.91, 92 Although, there 
is some uncertainty regarding prevalence estimatesC, existing data does not 
support the notion that iNPH is uncommon.  
In Germany, a door-to-door survey was conducted in order to examine the 
prevalence of Parkinsonism.93 The authors found a prevalence of iNPH, in 
persons above age 65 years, of 0.4%. However, because iNPH was only 
examined in those who screened positive for Parkinsonism, the study 
probably underestimated the prevalence. A study from Norway reported a 
prevalence of probable iNPH of approximately 0.1 % in persons older than 65 
years.94 However, this study was not populations based. Participants were 
recruited from an advertisement campaign directed to the general population 
and primary care physicians. It is thus possible that the low prevalence was 
due to recruitment bias.  
A population-based study in Tajiri, Japan found a prevalence of NPH of 2.9 % 
among 170 men and women aged 65 years or older.95 Another population-
based study from the same area examined 497 persons aged 65 years or 
more and reported a prevalence of possible iNPH of 1.4%.96 A third 
population-based study from Japan included 790 persons and found that 
                                                      
C One of the reasons for having uncertainty in the prevalence estimates might be that 
iNPH, like many other neurological diseases is rather difficult to diagnose. The brain is 
a highly complex organ shielded by thick bone and isolated from the rest of the body 
by a blood-brain-barrier. Advanced imaging techniques and extensive workup are 
often needed to make an accurate diagnosis. Thus, making a precise diagnosis on a 
population-level is difficult and may require substantial resources. 
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1.5% had features of NPH on MRI, and 0.5% met the criteria of possible 
iNPH.97 These studies included mainly younger elderly. A study, conducted in 
Umeå, Sweden examined the occurrence of ventricular enlargement and 
symptoms of iNPH among patients with TIA admitted to a stroke unit.98 The 
authors found that 3.9 % of the patients fulfilled radiological and clinical 
criteria for possible iNPH. Several other studies have been aimed to assess 
the prevalence of iNPH.99-101 However, these were not population-based. 
Instead, they were conducted on specific samples, such as patients from 
memory clinics or nursing homes and thus had inherent limitations. A recent 
systematic review pooled prevalence data from earlier population studies and 
found that the prevalence of iNPH, among persons aged 60 years or more, 
was 1.3 % (95 % CI; 0.96-1.71).102 
Two previous studies have examined the incidence of iNPH 94, 103, one of 
which was population-based.103 The first study was conducted in Norway and 
estimated the incidence among all ages to 5.5/100,000. The second one, 
conducted in Japan followed a cohort of 70-year-olds for ten years and 
estimated the incidence to 120/100,000. In Sweden, the annual incidence of 
shunt surgery for hydrocephalus is 3.33/100,000 104 (of which approximately 
half are for iNPH). The incidence of shunt surgery in Norway has been 
reported to be 1.09/100,000.105 Thus, extrapolating from earlier studies, 
existing data suggests that iNPH is highly underdiagnosed and undertreated. 
Using even the most modest estimates, it seems that less than 20 % of 
patients receive treatment. However, it should be pointed out that the number 
of shunt surgeries seems to have increased, at least in Japan, since these 
studies were published.106   
Diagnosis 
The diagnosis of iNPH is mainly based on the combination clinical signs and 
brain imaging findings from CT or MRI.1, 16 Certain additional tests of CSF 
dynamics may sometimes also be applied. Evidence-based guidelines for the 
diagnosis of iNPH have previously been developed in order to aid clinicians 
and provide consensus in research.  
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The first guidelines were created by several experts from Japan and 
published in 2004 (The English version was published in 2008).107 A second 
edition was made in conjunction with the Japanese Ministry of Health, and 
was published in 2011 (The English version, published in 2012).16   
In 2005, researchers from the USA and Europe also created separate 
guidelines for management of iNPH.1 According to these, iNPH should be 
diagnosed by careful review of the patient history, possibly also from a close 
informant, thorough clinical examination and neuroimaging. If diagnostic 
uncertainty remains, additional tests of CSF dynamics can be performed. 
However, despite meticulous review of the literature, the authors 
acknowledge the uncertainty and difficulties in diagnosing iNPH. For this 
reason, a classification system of “probable”, “possible” and “improbable” 
iNPH was proposed. The main signs and symptoms and diagnostic criteria 
are summarized in figure 5.  
Overall, the Japanese and American-European guidelines are rather similar. 
One differences is that gait disturbance is not mandatory for the classification 
of “probable iNPH” according to the Japanese guidelines.  Also, according to 
the Japanese criteria, persons who improve after shunt surgery can be 
labeled “definite iNPH”. This is not the case in the American-European 
guidelines.  
So far, the guideline criteria have not been validated regarding reliability, 
validity, sensitivity and specificity. Nevertheless, they have been of value in 
providing consensus and an evidence-based approach to the management of 
iNPH. Also, it is worth mentioning that in japan, the number of shunt 
surgeries for iNPH seems to have increased dramatically after the publication 
of the guidelines in 2004.106   
Patient history 
Clinical features of iNPH are also discussed in previous sections. Signs and 
symptoms of iNPH typically develop gradually.1, 16 A more acute onset should 
prompt the clinician to consider other diagnoses. Patients often present with 
gait and balance difficulties, unsteadiness and or increased number of falls.3 
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They may also present with signs of cognitive dysfunction, such as 
inattention, forgetfulness, drowsiness, increased sleep, lack of motivation as 
described earlier.9 Obtaining a medical and surgical history from a relative or 
other close informant is often of value considering that patients can 
sometimes have trouble recalling. Urinary symptoms, such as urgency and or 
incontinence are also common.4 However, urinary problems frequently occur 
in older persons without iNPH, due to other reasons. It is therefore important 
to distinguish symptoms in iNPH, which are thought to occur from overactivity 
of the detrusor, from other causes such as benign prostatic hyperplasia or 
stress incontinence. One should also bear in mind that some patients may 
find it difficult to discuss these types of symptoms. In addition, it is important 
to consider causes of secondary NPH, such as previous head trauma, 
meningitis or subarachnoid hemorrhage. Thus, past episodes of possible 
precipitants should be inquired. The possibility of congenital causes should 
also be considered. Treating physicians can therefore ask about neurological 
symptoms during childhood. Finally, there are several somatic and 
psychiatric disorders that can mimic iNPH. The presence of any comorbidities 
should thus be carefully reviewed.10  
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Figure 5. Overview and summary of the American-European guidelines 1 for the 
diagnosis of iNPH. 
MAIN	SIGNS	AND	SYMPTOMS	ACCORDING	TO	GUIDELINES	
Pa3ent	History
Progressive	symptoms	with	onset	aCer	the	
age	of	40.	Minimum	dura3on	of	3	months.	
No	evidence	of	secondary	NPH.	No	other	
concurrent	condi3ons	can	suﬃciently	
explain	symptoms	
Neuroimaging
Ventricular	enlargement	(Evans	Index	>	0,3).	
No	obstruc3on	of	CSF	ﬂow.	In	addi3on,	at	
least	one	of	the	following	features:	
Enlargement	of	the	temporal	horns.	
Periventricular	signal	changes.	Flow	void	on	
MRI.		
	
Clinical	Features
Gait:	Decreased	step	height,	length,	
cadance.	Increased	trunk	sway,	widened	
stance.	Outward	rotated	feet,	retropulsion.	
Impaired	balance.			
Cogni3on:	Decreased	psycho-motor	speed,	
ﬁne	motor	skill.	Decreased	a[en3on,	recall,	
and	execu3ve	dysfunc3on.		
Urinary	symptoms:	Episodic	or	persistent	
incon3nence,	not	a[ributable	to	urological	
disease.			
	
PROBABLE	iNPH	
	
Gait	and	Balance	disturbance	
+	
Cogni3ve	Impairment	or	
Urinary	Incon3nence	or	both	
	
POSSIBLE	iNPH	
	
At	least	one	of	the	following:	
Gait	and	Balance	
disturbance,	Cogni3ve	
Impairment	or	Urinary	
Incon3nence	
	
UNLIKELY	iNPH	
	
No	signs	of	ventricular	
enlargement,	Signs	of	
increased	intracranial	
pressure,	none	of	the	classic	
symptoms	present,	signs	and	
symptoms	a[ributable	to	
other	condi3ons		
	
Imaging	signs	consistent	with	iNPH	must	be	present	
SUMMARY	OF	GUIDELINE	CRITERIA	
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Assessment of gait and neuropsychology 
Gait and balance can be assessed in several ways. A clinical examination, in 
which a physician examines gait, including tandem gait and Romberg’s test, is of 
value. Additional examination by a physiotherapist may probably add more 
information. Also, formal testing, by measuring gait speed and number of steps is 
important in order to compare pre- and postoperative values. There are also many 
ways in which neuro-psychological evaluations can be done. Often the MMSE is 
performed. More specific testing of frontal-subcortical, executive functions and fine 
motor skills can be performed using the Stroop test, Grooved Pegboard test and 
the Rey Auditory Verbal Learning Test.18 Several other similar cognitive tests can 
also be applied.108  
Imaging in iNPH 
All patients with suspected iNPH must undergo imaging of the brain in order 
to examine ventricle size and exclude possible obstructions. A normal scan 
probably rules out iNPH rather effectively. According to the guidelines, 
ventricular enlargement is a mandatory criterion.1, 16 It is stated in the 
guidelines that ventricular enlargement should be evidenced by an Evans 
Index greater than 0.3, or by an equivalent measure of ventricles size. 
However, no such alternative measure is suggested.  
Regarding the choice of imaging,MRI is superior to CT in many ways. 
Although the guidelines do state that CT is probably sufficient for routine 
diagnosis of iNPH. Nevertheless, MRI allows for a better visualization of 
small obstructive lesions, including possible thin membranes.109 More 
advanced imaging techniques, such as measurements of cerebral perfusion 
by CT, MRI, SPECT, PET or pseudo-continuous arterial spin labeling 
(pCASL) have also been described.110-113 These have provided interesting 
results from an academic standpoint, but are currently not clinically applied. 
Additional methods, such as isotope cisternography114, have previously also 
been advocated, but currently lack evidence.1 
One of the major radiological hallmarks of iNPH is the presence of ventricular 
enlargement disproportional to subarachnoid space volume, i.e. ventricular 
enlargement not due to atrophy.8, 115 More specifically, the radiological 
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findings in iNPH have been described as a tightness of high convexity sulci 
and medial subarachnoid space, together with ventriculomegaly and enlarged 
Sylvian fissures (Figure 6). These findings have been termed DESH 
(disproportionately enlarged subarachnoid space hydrocephalus).8 According 
to studies based on clinical samples and population data, findings of DESH 
might differentiate iNPH from normal aging and vascular dementia.115-117 
Although, previous studies have provided promising results, additional 
research is needed to elucidate the exact diagnostic value. Dilation of the 
lateral ventricles is probably the most prominent sign, but most other parts of 
the ventricular system can also be enlarged.115 Optic nerve sheath diameter, 
which can be increased in conditions with increased intracranial pressure118, 
has not been studied in iNPH. 
Another radiological finding in iNPH that has recently gotten more attention is 
the narrowing of the corpus callosum angle on coronal sections. The first 
paper that measured the corpus callosum angle on MRI was published in 
2008.119 In that study, the angle was measured perpendicular to the antero-
posterior commissure plane, at the level of the posterior commissure. A sharp 
angle, less than 90°, differentiated iNPH patients from normal controls and 
those with Alzheimer’s disease. However, the patients with iNPH were pre-
selected based on clinical features and other imaging signs. Thus, the exact 
sensitivity and specificity cannot be determined, and further studies are 
needed to determine the exact prognostic value. 
White matter changes are also frequent imaging findings in iNPH.56 These 
may be both periventricular or located in the deep white matter.60 White 
matter changes are associated with small vessel disease and ischemia.55 
However, it sometimes also stated that the white matter changes in iNPH are 
caused by edema due to hydrodynamic disturbance of CSF circulation.4, 69 
Thus, the exact cause of these imaging findings is still the subject of some 
debate. However, the fact that iNPH is strongly associated with other 
vascular conditions46, 47, 49 probably indicates that ischemic processes are at 
least partly involved in the disease mechanisms. It should also be stated that 
cerebral ischemia may cause axonal demyelination, which can in turn, give 
rise to increased interstitial fluid. 
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Figure 6. Morphological changes in iNPH 
 
 
An increased CSF flow through the cerebral aqueduct, termed flow void, can 
sometimes be seen on MRI.120 This has been said to be suggestive of iNPH 
and have prognostic importance. However, previous studies have been 
contradictory121 and the exact value of this radiological sign is therefore not 
known. Regardless, the presence of a flow void is probably useful in 
differentiating communicating, from non-communicating hydrocephalus.  
Evans Index is and estimate of ventricle size, and is probably one of the most 
common imaging markers in the diagnosis of iNPH.122, 123 It is defined as the 
ratio between the maximum width of the frontal horns of the lateral ventricles 
and the maximum width of the inner diameter of the skull (Figure 7). Values 
Enlarged	
ventricles	
Dilated	
Sylvian		
ﬁssure	
Narrow	Corpus	
callosum	angle	
Occluded	sulci	
&	narrowed	
subarachnoid		
space	
NORMAL	BRAIN	 iNPH	
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higher than 0.3 are regarded pathological, and are currently required by 
international consensus guidelines for the diagnosis.1, 16 However, despite the 
fact that Evans Index is used extensively in both research and clinical 
practice, exact values in the adult population are not precisely known. Earlier 
studies reporting values on Evans Index were made using small samples or 
non-representative populations. Despite having a major role in the diagnosis 
of iNPH, no previous population-based epidemiological studies have reported 
reference values. 
Evans Index was first described in 1942 in children, using sagittal views on 
pneumoencephalograms.122 Later, in 1976, it was adapted for CT images.124 
In the original paper, Evans examined 53 children and concluded that a 
value, using the ratio between the frontal horns and the inner diameter of the 
skull, higher than 0.3 represents ventricular enlargement. Since then, this cut-
off value has been applied for the diagnosis of iNPH in older adults. Also, of 
interest, in the original paper Evans stated that there was less variation in 
ratio between the frontal horns and the skull, as apposed to just measuring 
the frontal horns. However, subsequently it was found that this was merely 
due to a miscalculation and that in fact the opposite was true.125  
In studies on healthy elderly, mean values for Evans Index have varied 
between 0.25 and 0.31.119, 126-128 In addition, population-based studies have 
reported prevalence values, of Evans Index higher than 0.3, varying between 
6.5 and 16.1 %.95-97, 116 However, these studies included mainly younger 
elderly and did not report mean values.  
Of further note, the exact method of measuring Evans Index has not been 
specified. In a study comprising ten iNPH patients, Evans Index was 
measured at different angles and sections in each patient and a considerable 
variation was noted.129 Another limitation regarding Evans Index is that it is 
not a direct measure ventricular volume, instead it might be regarded a 
surrogate marker. A previous study found that although Evans Index 
correlated highly with ventricular volume, it was not a reliable estimate of 
ventricle volume due to a wide prediction interval.126  
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Figure 7. Schematic illustration of Evans Index 
 
 
Overall, it might be that more advanced imaging of brain- and CSF spaces, 
such as volumetric analysis using MRI, would be of greater value in the 
diagnosis of iNPH. In an interesting study, a large representative, population-
based sample from Iceland was examined with MRI and clinical 
evaluations.117 Ventricle volume and subarachnoid space volume were 
measured. A large ratio between these two measures was associated with 
gait disturbance and cognitive impairment. These results suggest that the 
specific morphology of disproportional ventricular enlargement in relation to 
the high convexity sulci might better indicate iNPH (As opposed to just 
measuring ventricle size, which may also capture patients with atrophy to a 
large extent).  Additional studies, using smaller samples, have shown that 
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measurement of ventricular volume in relation to cortical thickness and 
subarachnoid space volume might be of value in differentiating iNPH from 
other neurodegenerative diseases.130, 131  
Finally it is important to discuss the fact that ventricle size does not appear to 
correlate with improvement after CSF diversion.132, 133 If this is true, then it 
might not be meaningful at all to have a have a certain defined cut-off for 
either Evans Index or any other measure of ventricle size. For example, it is 
not known whether patients with symptoms of iNPH who have values of 
Evans Index less than 0.3 could respond to treatment.   
CSF tap-test  
The CSF tap test is a well-known diagnostic test for iNPH. CSF is removed 
through a lumbar puncture after which the patient is evaluated for possible 
improvement.134 The CSF tap test has been used for the diagnosis of iNPH, 
and prediction of who will benefit from treatment, for several decades. 
However, the predictive value of the CSF tap test is not precisely known. The 
exact way of carrying out the test has not been standardized.42 For example, 
the amount of CSF removed has varied between 30 and 50 ml. Also, the 
specific types of clinical evaluations and time between CSF removal and 
clinical evaluation have varied. Different authors have also used different cut-
off criteria for the classifying patients as improved or not. According to a 
recent systematic review 135 the average sensitivity, for a favorable treatment 
outcome, was 58 % (ranging from 26 % to 87 %). The average specificity 
was 75 % (ranging from 33 % to 100 %). Thus, current data suggests that the 
CSF tap test is not suitable for ruling out patients from treatment and has, an 
overall, rather limited clinical value.  
CSF Infusion tests 
Various aspects of CSF dynamics can be measured using so-called infusion 
tests. More precisely, the resistance of CSF outflow (Rout) can be calculated 
by infusing saline through a lumbar puncture. Increased CSF outflow 
resistance, i.e. a high Rout, has been said to be an important diagnostic 
marker and predictor of shunt response.38 It is thus often used in the clinical 
work-up of iNPH. However, when considering existing data, CSF infusion 
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studies are probably not reliable for diagnosing iNPH and should not be used 
for selecting candidates for shunt surgery. Values of Rout, that are believed to 
indicate iNPH, may be found in as many as 25 % of healthy elderly.41 In 
addition, a more recent, large prospective cohort study found no relation 
between CSF outflow resistance and outcome after shunt surgery.90 
Therefore, similar to the tap-test, measurement of CSF outflow resistance is 
probably of limited value.  
Treatment 
Diversion of CSF by a surgically placed shunt catheter is currently the only 
evidence-based treatment of iNPH.136 Different methods of CSF drainage can 
be applied. The most common include placement of a ventriculo-peritoneal 
shunt, in which the proximal catheter tip is inserted in the lateral ventricles 
and the distal end within the peritoneal cavity.137 Similarly, in ventriculo-atrial 
shunts the proximal tip is within the lateral ventricles, but the distal end is 
placed in the right atrium of the heart.138 In lumbo-peritoneal shunts, the 
proximal end of the catheter is placed within the dura mater in the spinal 
canal, and the distal end within the peritoneal cavity.139 Many other locations 
for shunt placement have previously been described, but have not gained 
acceptance.140  
So far most studies on the treatment in iNPH have been non-blinded and 
made without control groups. High-level evidence, such as randomized 
controlled trials (RCT’s), has so far been scare.141 However, several well-
conducted observational studies have indicated that iNPH patients may 
benefit substantially from shunt surgery. It might also be of interest to point 
out that the difference between observational studies and RCT’s may 
possibly be overstated. RCT’s are often considered to be the gold standard of 
evidence. However, two earlier papers have compared RCT’s to 
observational studies by examining several different disorders in various 
research areas.142, 143 The studies found that the effects estimated by RCT’s 
and those estimated by observational studies were highly similar. 
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Of further note, there is one previous RCT that has compared ventriculo-
peritoneal shunting to placebo.67 However, the study has so far received 
surprisingly little attention. In that study, iNPH patients with concomitant 
Binswanger’s disease were randomized to receive either a standard 
ventriculo-peritoneal shunt, or a ligated shunt. Both patients and caregivers 
were blinded to the intervention. Three months post-randomization, patients 
in the treatment arm improved while no improvement was noted in the control 
group. When the ligated shunts were opened in the control patients they to 
improved. Despite the fact that only fourteen patients were included, 
significant differences were detected. The study was stopped early after 
interim analysis. 
One important observational study has provided further evidence for CSF 
diversion.144 The study sample consisted of 33 iNPH patients who were 
inadvertently subjected to a severe delay of treatment (more than six months, 
due to a major administrative failure of the hospital). These were compared to 
69 patients who were treated in normal fashion, within three months. A 
substantial deterioration occurred in those with delayed treatment, while 
those treated within three months improved. Although the study actually 
intended to examine the natural history of iNPH, it may also be regarded as a 
study on the effect of treatment based on a within-subject design. It is 
reasonable to assume that that the administrative failure leading to delayed 
treatment affected patient groups at random. Therefore, the study could be 
considered a natural experimentD, which might allow for causal inference, at 
least to some extent.145, 146  
A systematic review, published in 2013, examined 64 studies comprising 
more than 3,000 patients.147 According to the results of this paper, the 
percentage of patients improving after shunt surgery has increased 
considerably over the past decades. According to the studies published 
                                                      
D Natural experiments can be described as studies in which randomization is not 
performed by the researchers, but instead occurs due to an exogenous, chance 
phenomenon. They can provide important information and allow for causal inference 
in circumstances when randomization is not ethical or impractical for various other 
reasons. These types of studies are common in economics.   
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during the last five years, an estimated 82 % of patients improved after 
treatment. Moreover, during the past decades, shunt-related mortality, 
morbidity and revision rates have decreased substantially. 
Improved cognition after shunt surgery has been reported in several 
studies43, 148, 149 including a recent meta-analysis150 that showed improved 
global cognitive function as well as enhanced memory and psychomotor 
speed. 
In a European multicenter study, 142 iNPH patients, from thirteen centers in 
nine countries were included.151 All patients were treated with shunt. At 
follow-up, after one year, 69 % had improved at least one level on the 
modified Rankin scale152 (mRS). Almost one third of the sample improved two 
or three levels. The percentage of patients being able to live independently 
increased from 53 %, before surgery to 82 % after. Based on the outcome of 
an iNPH-scale153, 84 % of the patients were classified as improved (≥ 5 
points).     
In the SINPHONI-study8, another large multicenter study, consisting of 26 
centers in Japan, 100 iNPH patients were treated with a ventriculo-peritoneal 
shunt. The primary outcome was improvement of the mRS. Secondary 
outcome measures were based on an iNPH grading scale140, timed “Up & 
Go” test, and the mini mental state examination (MMSE). Follow-up 
examinations were conducted at 3, 6 and 12 months after shunt surgery. 
Almost 70 % of the patients improved at least one level on the mRS. The 
percentage of patients who improved to mRS ≤ 1 (i.e. no functional 
impairment) increased from 7 % to 44 % after treatment. The mean value of 
MMSE increased from 23 to 25 after treatment. Significant improvement was 
also noted in all other secondary outcome measures.  
The SINPHONI-2, a subsequent study, was a prospective randomized 
controlled trial that included 93 patients from 20 different centers.154 Study 
participants were randomly assigned to receive shunt surgery or conservative 
management over a three-month period. At follow-up, three months after 
randomization, 65 % of those treated with a lumbo-peritoneal shunt improved 
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≥ 1 level on the mRS, compared to only 5 % in those with conservative 
therapy. Almost all other tests of gait, cognition and caregiver burden also 
indicated significant improvement in the treatment arm. However, it is 
important to note that the study was neither sham-controlled nor blinded. 
Nevertheless the findings are important and indicate that CSF diversion is 
beneficial. Comparing results from the SINPHONI and SINPHONI-2 trials, 
lumbo-peritoneal shunts seem to have a slightly higher revision rate, but 
similar safety and efficacy compared to ventriculo-peritoneal shunts.155 Head-
to-head studies have however so far not been conducted. 
Assessment of outcome after shunt surgery 
There is no standard measure of outcome in iNPH. Thus improvement after 
treatment has been defined in different ways in different studies. A commonly 
used method to evaluate outcome is the mRS. However, it is important to 
bear in mind that change in mRS is a rather crude outcome measure. This 
implies that only substantial changes can be detected. It is therefore plausible 
that the mRS is less prone to placebo-effect and observer bias. Evaluation 
can also be made using a specific outcome scale for iNPH.153 This covers 
four symptom domains (gait, balance, cognition and urinary incontinence) 
and includes both ordinal and continuous variables. The scale is calibrated 
and norm-based. Several other scales156, 157 have also been developed, but 
have not gained acceptance.   
Prognosis 
Mortality in iNPH patients, treated with shunt, has been found to be 
approximately two to three times higher than in the general population, and 
similar to patients with stroke.158-160 So far, almost all studies regarding the 
prognosis in iNPH have been based on convenience samples.161-163 
Furthermore, there is little data on the natural course, i.e. prognosis in 
untreated patients.164  
As mentioned in the previous section, an earlier study examined the 
progression of hydrocephalic symptoms in a group of iNPH patients who 
were unable to undergo treatment due to a severe delay by the hospital.144 
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The study found that untreated patients deteriorated considerably, with 
worsening gait and cognition. However, there are currently no 
epidemiological studies regarding the natural course. Furthermore, it is not 
known whether treatment with shunt surgery increases survival.  
Although cognitive impairment is one of the main symptoms in iNPH, the risk 
of developing dementia is not precisely known. A recent study from a large 
registry-based sample consisting of patients with suspected iNPH showed a 
high risk of cognitive impairment and dementia in both shunted and non-
shunted individuals during a follow-up period of over 4 years (46 % of shunt 
responders were eventually diagnosed with dementia).165 However, all 
patients who were diagnosed with iNPH received shunts. Thus, the non-
shunted patients had other diagnoses, such as Alzheimer’s disease or 
vascular dementia. Also, the decision to shunt was based on results from 
intracranial pressure monitoring which might have biased the results. 
Nevertheless, the findings indicate that iNPH is an important cause of 
dementia. Early diagnosis and treatment is probably crucial. 
 
 
 
 
 
 
 
 
 
 Never before in human history has the population 
been as aged as currently. Over the last fifty years, 
the number of older persons has tripled. 
Furthermore, the number of older persons is 
expected to triple again over the next fifty years. 
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2 THE AGING SOCIETY AND THE AGING 
BRAIN 
 
 
The world’s older population is increasing rapidly in almost all countries. 
Currently, approximately 12 % of the world’s population is aged 60 years or 
more.166 By 2050, this number is expected to increase to more than 21 % 
(Figure 8). Furthermore, the older population is aging as well. The number of 
persons aged 80 years or more, is projected to triple over the next thirty to 
forty years.167 Several major challenges lie ahead for societies throughout the 
world. However, given improved health and increased longevity, population 
aging can also be viewed as a success for mankind.  
The causes of population aging include decreased mortality, in particular due 
to decreased tobacco use and decreased mortality from cardiovascular 
diseases.168 Declining fertility is also an important cause.166 Interestingly, 
there seems to be a continuing trend for decreasing mortalityE and current 
data does not support the theory that humans are reaching a theoretical 
upper age-limit.168 For more than 160 years, life expectancy in the record-
holding countries has been increasing by almost three months per year.169 
Also, based on long-term trends, there is no indication that the increase in life 
expectancy is abating.169 Indeed, this raises an intriguing question. What is 
the maximum life span of a human being?  
                                                      
E In the year 1800, average life expectancy in Sweden was less than 40 years. In 
1900, this number had increased to slightly higher than 50 years. Today, the average 
life expectancy is more than 80 years (Source: UN Demographic yearbook and 
Statistics Sweden, SCB).   
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Figure 8. Population aging (Adapted from World Population Ageing 2013 by 
United Nations, Department of Economic and Social Affairs, Population Division, 
© 2013 United Nations. Reprinted with the permission of the United Nations) 
 
Potential Social and Economic Consequences 
Increased longevity and population aging poses several important economic 
and societal challenges. Indeed, major interventions are needed to cope with 
these concerns. Such interventions might be to raise retirement age, 
decrease benefits or increase taxes. However, the rapid increase in 
population age is historically unprecedented. Therefore, fundamental reforms 
with innovative reorganization of health care policies and welfare systems are 
required.  
Population aging has been described as a major threat to societies with 
potential devastating consequences such as increased suffering and possible 
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economic collapse.170 However, some of these worries are probably 
somewhat overstated.171 It is important to emphasize that several factors 
could attenuate the cost of having an older population. For example, 
decreased fertility can result in an increased workforce.F Immigration may 
possibly also lessen the burden of a diminishing workforce. Similarly, 
increased retirement age might be an option for at least parts of the 
population. Another option could be to allow persons to work fewer hours per 
week in exchange for working more years. Moreover, adherence to healthier 
lifestyles, including smoking cessation and reduced alcohol intake, might 
reduce the incidence and cost of various non-communicable diseases. 
Improved education, and prevention of diseases could further augment 
healthy aging, reduce disability and associated healthcare costs. Future 
technological advances can also act to increase health and well-being at 
lower costs. Also, it seems that individuals are not merely becoming older, 
but are reaching old age with better health.172 Furthermore, regardless of 
economic implications, societies would probably benefit from changing the 
perceptions on high age, abandon stereotypical views and eliminate 
discrimination. 
Dementia and the aging brain 
Dementia and cognitive impairment mainly affects older persons and is one 
of the most important causes of disability and global burden of disease.173 
Progressive cognitive deterioration with loss of independence has 
catastrophic consequences for both patients and relatives. Alzheimer’s 
disease and vascular dementia are the most common causes of dementia.174 
However, there are probably many other neurological disorders (including 
iNPH) that, in total, also account for a large number of cases of cognitive 
impairment. Currently, approximately 40 million people around the world 
suffer from dementia, and the number is expected to double every twenty 
                                                      
F ”Contraception and the Celtic Tiger” is the title of a paper published in 2003, by the 
Harvard economists David Bloom and David Canning. In 1979, the Irish government 
lifted their ban on contraception. As a result, fertility decreased suddenly and the 
dependency ratio, i.e. proportion non-working individuals to working individuals, 
accordingly decreased. The number of active persons in the workforce rose 
substantially and the country witnessed a remarkable economic growth.  
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years, reaching more than 115 million by 2050.175 The cost of dementia, in 
2010, was estimated to be equivalent of 1 % of the worlds GDP.176, 177 
However, there are reasons for optimism. For example, the occurrence of 
dementia seems to be decreasing despite population aging.178, 179 Also, more 
recently possibilities for primary and secondary prevention have been 
emerging.180 As we continue to fill knowledge gaps, hopefully lifestyle 
changes and enhanced living conditions as well as increase in education and 
socioeconomic reforms may lead us to a better future with improved well-
being throughout higher age.     
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3 AIM 
 
 
The overall aim of this thesis was to examine the epidemiology of iNPH. This 
included the prevalence, risk factors, estimated ventricle size in the general 
population, and long-term outcome among untreated individuals. The thesis 
is based a representative population-based sample of men and women aged 
70 years or more.  
Paper 1 
The aim of the first paper was to determine the prevalence of probable iNPH, 
and occurrence of radiological signs consistent with iNPH.  
Paper 2 
The aim of the second paper was to examine vascular risk factors and WMLs 
in relation to clinical and imaging signs of iNPH, using a nested case-control 
analysis.  
Paper 3 
In paper three, the aim was to examine ventricle size and provide reference 
values for Evans Index (a diagnostic marker for iNPH). 
Paper 4 
The aim of the fourth paper was to study long-term outcome among untreated 
individuals with probable iNPH and persons with imaging signs of iNPH. 
Outcomes were mortality, dementia and progression of hydrocephalic 
symptoms.  
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4 METHODS AND STUDY DESIGN 
 
Study sample - The Gothenburg Population Studies     
The Gothenburg population studies include several representative cohorts, 
followed for almost fifty years. The studies consist of detailed examinations 
designed to investigate aging and age-related disorders. All participants were 
systematically obtained from the Swedish population register based on birth 
dates, and included people living in private households and in residential 
care. The examinations comprised physical and psychiatric examinations 
including laboratory and radiological work-up. Also, house-visits, telephone 
interviews, close-informant interviews and non-respondent analyses were 
made. In addition, the studies were complemented with data from the 
Swedish national inpatient register and Swedish cause of death register. For 
the present thesis, data from the following cohorts were included.  
The Population Studies of Women 
The Population studies of women (PPSW)181, 182 began in 1968 and baseline 
examinations included women aged 38 to 65 (born between 1914 and 1930). 
The PPSW is currently still ongoing. 
The Longitudinal Gerontological and Geriatric Population Studies and H85 
Studies in Gothenburg  
The Longitudinal Gerontological and Geriatric Population Studies (H70) and 
H85-cohorts183-186 are population-based cohort studies that began in 1971. 
Similar to the PPSW, the examinations included comprehensive assessments 
of somatic and psychiatric disorders, physical examinations including blood 
test, lumbar puncture, ECG, radiological examinations, anthropometric 
measurements and data on psychosocial background factors and 
psychometric tests. The first examinations included 70-year old men and 
women born in 1901-02. Follow-up examinations have been conducted at 
various ages. In 1986, a follow-up examination was conducted and the 
prevalence of dementia was determined with the help of CT imaging of the 
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brain.183 At the time, the sample included approximately half of all 85-year 
olds in Gothenburg. The cohort examined in 2000 (70-year-olds born in 1930) 
was merged with PPSW cohort, i.e. they were examined together.  
The Nordic Research on Ageing Studies 
The Nordic Research on Ageing (NORA)187 studies began in 1990 and were 
conducted in Gothenburg, Sweden, and additional sites in Denmark and 
Finland. The sample included 75-year-olds at baseline, and follow-up was 
made five years later at age 80. For the present thesis, only those examined 
in Gothenburg were included. 
Study population in papers I-VI 
We merged data from the studies described above, and included all persons 
who underwent one or more CT examination of the brain between 1986 and 
2000. All participants were aged 70 years or more at baseline. An overview of 
the cohorts is shown in the figure 9.  
 
A total of 3246 individuals were invited to take part and 2182 accepted 
(response rate 67 %), with no significant difference in response rate between 
men and women (65 % versus 68 %; p=0.107). Of those who took part in the 
clinical examinations, 1238G underwent a CT scan of the brain (response rate 
58 %; 60 % for men and 56 % for women; p=0.067). The selection of study 
participants is shown in figure 10. Participants in the CT study were on 
average slightly younger and performed better on the Mini Mental State 
Examination (MMSE). There were no significant differences in the prevalence 
of dementia or major depression between the CT group and non-CT group 
(table 1). Also, the participants in each cohort were similar to non-participants 
regarding several demographic factors such as age, sex, marital status, 
mortality and various psychiatric illnesses. Thus, the sample can considered 
                                                      
G Correction: Subsequently it was noted that two persons had undergone CT imaging 
but had no other clinical data. These were therefore excluded. Also, one person was 
found to be less than 70 years at the time of CT. This person was therefore also 
excluded. After re-analyzing the data, these changes were did not alter any results 
significantly. However, in paper I results are presented based on a sample of 1238 
while subsequent studies included 1235 participants. 
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representative of the population. However, due to having merged individual 
cohorts, unbalance occurred in the total data set, in particular regarding age 
groups and sex. The distribution of the merged sample is shown in table 2.  
 
Figure 9. Gothenburg population studies, overview of the cohorts included in this 
study 
The sample comprised data from four prospective cohort studies. NORA = Nordic 
Research On Ageing, PPSW = Prospective Population study of Women, H85-H90 
and H70 = Longitudinal Gerontological and Geriatric Population Studies in 
Gothenburg, Sweden. Baseline examination was considered at time of first CT. All 
persons were aged 70 years or more at baseline. Data from the Swedish National 
Inpatient Register and the Population Register was available until 2012 
 
 
2000 
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2009 
2000 
1990, 
1991 
1995, 
1996 
 
PPSW Studies 
Birth cohorts 1908, 1914,  
1918, 1922, 1930 
2005 Women aged 70 + years 
Women aged 70 + years 
Women aged 70 + years 
1986, 
1987 
1989,  
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1991,  
1992 
 
H85 Studies 
Birth cohorts 1901, 1902 
85 year-olds 
88 year-olds 
90 year-olds 
NORA Studies 
Birth cohorts 1915, 1916 
75	year-olds	
80 year-olds 
Women aged 70 + years 2009 
H70 Studies 
Birth cohort 1930 
70	year-olds	
75 year-olds 
1992 
79 year-olds 
Pooled sample (n = 1235) 
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Figure 10. Selection of study participants (three CT-participants were 
subsequently excluded) 
 
 
 
 
 
 
 
 
 
Pooled	sample	
Number	of	persons	invited	
n=3246	
Par9cipants	
n=2182	
Non-Par9cipants	
n=1064	
CT-Par9cipants	
n=1238	
Non-CT	Par9cipants	
n=944	
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Table 1. Comparison between CT participants and non-CT participants  
  
 
Non-CT Group 
(N=944) 
 
 
 
CT Group 
(N=1235)a p-value 
Women, % 76.4 72.9  0.067 
Dementia (DSM-III-R), % 12.0 10.8 0.401 
Major depression, % 8.4  6.7 0.136 
Mean age (SD) 77.2 (6.4) 74.7 (6.0) <0.001 
Mean MMSE score (SD) 26.1 (5.9) 26.8 (5.0) 0.002 
Legend: DSM-III-R=Diagnostic And Statistical Manual of Mental Disorders, 3rd 
edition revised, MMSE= Mini-Mental State Examination, SD=Standard Deviation. 
a=Two persons were excluded due to complete lack of data. In addition, one 
individual was subsequently noted to be less than 70 years at baseline. This person 
was therefore also excluded.  
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Table 2. Distribution of study participants according to gender and cohort 
 Gender  
 
Cohort 
Women 
% (n) 
Men 
% (n) 
Total 
% (n) 
H85 Studies (85-year-olds) 18.0 (162) 22.0 (74) 19.1 (236) 
H88 Studies (88-year-olds) 2.6 (23) 2.7 (9) 2.6 (32) 
H90 Studies (90-year-olds) 0.2 (2) 1.8 (6) 0.6 (8) 
NORA Studies (75-year-olds) 1.9 (17) 5.4 (18) 2.8 (35) 
NORA Studies (80-year-olds) 4.4 (40) 11.4 (38) 6.3 (78) 
PPSW/H70 Studies (Ages 70+) 35.7 (321) 0.0 (0) 26.0 (321) 
PPSW/H70 Studies (Ages 70+) 37.2 (335) 56.7 (190) 42.5 (525) 
Total 100 (900) 100 (335) 100 (1235) 
Legend: H85-H90 and H70 = Longitudinal Gerontological and Geriatric Population 
Studies in Gothenburg, Sweden, NORA = Nordic Research On Ageing, PPSW = 
Prospective Population study of Women.  
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Radiological Examinations 
Between 1986 and 2000, study participants underwent CT imaging of the 
brain. All scans were in the transverse plane, and no contrast was used. 
Three observers, a medical studentH, a resident in neurosurgeryI and a 
consultant in neurologyJ, collectively made an initial screening assessment of 
all CT images. The observers were, at the time of the image assessments, 
unaware of clinical data. Each case was evaluated for hydrocephalic 
ventricular enlargement, i.e. radiological findings consistent with iNPH. This 
was based on previous descriptions in the literature 1, 8, 59, 188, and was 
defined as enlargement of all four ventricles without equivalent widening of 
cortical sulci or obstruction of CSF flow or structural lesions. Persons with 
extracerebral mass lesions or other pathologies influencing ventricular 
morphology were excluded. The presence of WMLs was not considered for 
the diagnosis. Cases in which ventricular dilation was caused by conditions 
other than NPH, such as brain atrophy, obstructive hydrocephalus or loss of 
brain parenchyma were not considered as hydrocephalic ventricular 
enlargement. Evans Index was measured in all cases, and defined as the 
ratio between the largest width of the frontal horns and the largest inner 
diameter of the skull. Occluded sulci at the high convexity (OccSul) was 
defined as not having any sulcus extending to the midline at the falx cerebri 
on the two uppermost CT slices. A consultant neuroradiologistK re-evaluated 
all images that in the initial assessment screened positive for hydrocephalic 
ventricular enlargement or had uncertain findings. The neuroradiologist made 
the final diagnosis in all cases.  
Diagnosis of iNPH 
The diagnosis of iNPH was based on the results of the imaging findings, 
clinical examinations and data from interviews. This was made in 
concordance with criteria from the American-European iNPH guidelines.1 
                                                      
H Daniel Jaraj (Then medical student, now licensed physician) 
I Katrin Rabiei (Then Neurosurgical resident, now specialist in Neurosurgery) 
J Carsten WikkelsØ (Consultant physician and Professor of Neurology) 
K Christer Jensen (Consultant physician, specialist in Neuroradiology) 
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History of severe head trauma, meningitis or subarachnoid bleeding were 
exclusion criteria. 
Gait disturbance was assessed by evaluating data from clinical examinations 
and interviews. Physicians, specializing in geriatrics, performed physical 
examinations in which a general assessment of gait was made. The 
examiner graded walking difficulties as non-existent, slight or extensive. 
Participants had also been asked questions regarding gait and walking 
difficulties on interviews. Gait disturbance was defined as presence of any 
walking difficulty on examination and/or presence of self-reported walking 
difficulty. Cognitive function was evaluated with the Mini Mental State 
Examination (MMSE). A score of 25 or less was defined as cognitive 
impairment. Urinary incontinence was assessed by self-report, and defined 
as involuntary leakage of urine occurring more than once per week. 
Probable iNPH was diagnosed in participants who had hydrocephalic 
ventricular together with gait disturbance and one of either MMSE ≤ 25 or 
urinary incontinence. Possible iNPH was diagnosed in persons with 
hydrocephalic ventricular enlargement and at least one other core clinical 
sign of iNPH, i.e. gait disturbance, MMSE ≤ 25 or urinary incontinence. 
Papers I – IV 
 
Paper I 
The prevalence of probable iNPH, and radiological signs of iNPH, was 
calculated by dividing the number of persons with each finding by the total 
number of study participants. Crude prevalence rates regarding age group 
and sex were compared using the Fisher’s exact test. In addition, the 
association between radiological signs, and symptoms of iNPH were 
examined using multiple binary logistic regression models adjusting for age 
and sex.  
 
Daniel Jaraj 
51 
Paper II 
In the second paper the relation between WMLs, vascular risk factors and 
iNPH was examined. Radiologists, unaware of the clinical data, evaluated 
WMLs on CT. This was made independently of the evaluations for 
hydrocephalic ventricular enlargement (i.e. by different radiologists). WMLs 
were defined as low-density areas in the periventricular and subcortical white 
matter and graded as not present, mild, moderate or severe. In the analyses 
for the present paper, WMLs were classified as moderate to severe vs not 
present or only mild. Data on vascular risk factors was obtained from clinical 
evaluations, interviews and the Swedish National Inpatient Register. This is a 
validated national health care register that currently records more than 99 % 
of all hospital discharges in Sweden.189 Hypertension, diabetes mellitus (type 
1 or type 2), stroke/TIA, and coronary artery disease were defined as present 
if a person had a diagnosis in the national inpatient register, or a self-reported 
diagnosis as told by a physician. In addition, smoking was classified as past 
or present cigarette smoking vs never having smoked. Overweight was 
defined as a body mass index > 25 kg/m2.  
In the analyses, two groups of cases were defined: Those with hydrocephalic 
ventricular enlargement (labeled HVe), i.e. imaging findings consistent with 
iNPH, and those who fulfilled criteria for probable iNPH (labeled suspected 
iNPH). A nested case-control design was applied. Thus for each case, in both 
groups, five controls were randomly selected from the total sample. These 
were matched for age, sex and cohort. The controls consisted of persons 
without imaging signs of iNPH. Cases and controls were compared using 
Pearson’s x2 test, the Cochran-Mantel-Haenszel test. In addition, in order to 
examine independent associations for each risk factor, conditional logistic 
regression models were made.  
Paper III 
In all cases, the size of the frontal horns of the lateral ventricles was 
assessed and Evans Index was measured. This was made by the three 
observers, as described previously. Evans Index was defined as the ratio 
between the maximum width of the frontal horns and the maximal width of the 
inner diameter of the skull. Images were also evaluated for findings 
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consistent with iNPH as described above. All uncertain cases were 
reevaluated by a neuroradiologist.  
Descriptive statistics were examined for the total sample and subgroups 
based on sex and age. Mean and median values as well as dispersion, 
distribution and outliers were assessed using the descriptive data, histograms 
and box-plots. Independent sample t-tests were used to compare mean 
values between groups. Evans Index was also dichotomized as > 0.3 vs < 
0.3 and differences were tested using the Pearson’s x2 test. Statistical 
analyses were made using SPSS version 22.0 (SPSS Inc., Chicago, IL) and 
R version 3.2.2.190 
Paper IV 
Baseline examinations were performed between 1986 and 2000. One, or 
more, follow-up examination was made for all cohorts until 2009 (figure 9). 
Median follow-up time was 11.5 years (interquartile range 6.5 years) with a 
maximum follow-up of 25 years. Data was obtained from the somatic and 
psychiatric examinations, interviews, close-informant interviews and 
complemented with data from the Swedish National Inpatient Register.  
Possible iNPH and probable iNPH was diagnosed in accordance with criteria 
from international consensus guidelines, as described previously. Dementia 
was diagnosed by geriatric psychiatrist using the Diagnostic and Statistical 
Manual of Mental Disorders (third edition, revised) criteria. Date of death was 
obtained from the Swedish Population Register (National Board of Health and 
Welfare’s Cause of Death Register). This is a national register that is 
complete regarding mortality among all Swedish residents both in Sweden 
and abroad.191  
Progression to probable iNPH, from possible iNPH or asymptomatic 
hydrocephalic ventricular enlargement, was evaluated using criteria the 
American-European iNPH guidelines. This was made using data from the 
clinical examinations and the Swedish National Inpatient Register. The 
development of gait disturbance cognitive impairment or urinary incontinence 
was also assessed in those with hydrocephalic ventricular enlargement who 
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were asymptomatic at baseline.  
Among those with hydrocephalic ventricular enlargement (n=55), two persons 
had previously been treated with shunt surgery and were therefore excluded 
from all analyses. In the analyses, outcomes were examined for all those with 
hydrocephalic ventricular enlargement. In addition, they were divided into the 
following subgroups: those with probable iNPH (n=24), and those with 
possible iNPH or asymptomatic ventricular enlargement (n=29).  
The date of the first CT examination was considered as baseline. All 
comparisons were made with individuals without hydrocephalic ventricular 
enlargement (n=1180). Crude five-year mortality was compared between 
groups using the Pearson’s x2 test. Mortality and risk of dementia was also 
examined using Kaplan-Meier survival curves, the Log-rank test and Cox 
proportional hazard models for each group. The models were adjusted for 
baseline age, sex, and cohort. In addition, a binary logistic regression models 
was made to examine the association between hydrocephalic ventricular 
enlargement (all cases, n=53) and risk of dementia at any time during the 
study, i.e. baseline and follow-up. Adjustment was made for baseline age, 
sex and cohort. Statistical analyses were made using SPSS version 22.0 
(SPSS Inc., Chicago, IL) and R version 3.2.2.190 
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5 RESULTS AND DISCUSSION 
 
 
Paper I 
The prevalence of iNPH, in the total sample (n=1238) was 2.1 %. Stratifying 
by age groups, the prevalence was 0.2 % in those aged 70-79 years, and 5.9 
% in those aged 80 years or more (Table 3). There was no difference in the 
prevalence regarding sex. However, the prevalence was strongly related to 
being older than 80 years (OR 35.5; 95 % CI 4.8-262.7). The prevalence of 
imaging findings of iNPH is shown in table 4. The relation between symptoms 
of iNPH and radiological findings is shown in table 5. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Paper I 
PREVALENCE 
 
80 YEARS OR MORE 
 5.9 % 
0.2 % 70-79 YEARS 
PREVALENCE OF PROBABLE iNPH BY AGE GROUPS  
 
MORE THAN 1 IN 
TWENTY AMONG 80-
YEAR-OLDS HAD 
PROBABLE iNPH 
4.5 % OF THE TOTAL SAMPLE HAD A CT IMAGE 
CONSISTENT WITH iNPH (HcVe)
PREVALENCE OF 
PROBABLE iNPH IN 
THE TOTAL SAMPLE 
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Table 3. Prevalence of probable iNPH by age group and gender (N=1238)  
 
Age groups Men %(n/N) Women % (n/N) Total % (n/N) 
70-79 0.5 (1/208) 0.2 (1/626) 0.2 (2/834) 
80 + 7.1 (9/127) 5.4 (15/277) 5.9 (24/404) 
Total 3.0 (10/335) 1.8 (16/903) 2.1 (26/1238) 
Legend: n= The number of persons with probable iNPH. N= The number of 
persons included in this study. Prevalence in 70-79 vs 80+ p <0.001, 
Prevalence in men vs women p = 0.186 
 
 
Table 4. Prevalence of Hydrocephalic Ventricular Enlargement (HcVe), Evans Index 
(EI) > 0.3, and Occluded sulci by sex and age groups (N=1238)   
 
 Men % (n=335) Women % (n=903) Total % (n=1238) 
 70-79 80+ Tot. 70-79 80+ Tot. 70-79 80+ Tot. 
HcVe 
5.3 
(11) 
11.0 
(14)NS 
7.5   
(25) 
1.4   
(9) 
7.4 
(22)d 
3.4 
(31) a 
2.4 
(20) 
8.9 
(36) d 
4.5 
(56) 
EI>0.3 
23.6 
(49) 
46.5 
(59) d 
32.2 
(108) 
9.9 
(62) 
31.0 
(86)d 
16.4 
(148)b 
13.3 
(111) 
35.9 
(145) d 
20.7 
(256) 
Occluded 
Sulci 
6.3 
(13) 
11.0 
(14) NS 
8.1   
(27) 
3.8 
(24) 
5.8 
(16) NS 
4.4 
(40) a 
4.4 
(37) 
7.4 
(30)c 
5.4 
(67) 
Legend: Data are in percentages 
a = p<0.005, b = p<0.001: differences between sex, 
NS = p≥0.05, c = p <0.05, d = p<0.001: differences between age groups 
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Table 5. The relation between clinical and CT features of iNPH 
 
 Gait disturbance  
% (n/N) 
Cognitive impairment 
% (n/N) 
Urinary incontinence 
% (n/N) 
Reference group    
Frequency 12.1 (114/941) 8.6 (81/942) 10.3 (77/745) 
HcVe    
Frequency 61.1 (33/54) 55.6 (30/54) 45.8 (22/48) 
OR (CI) 9.9 (5.2–18.9) 10.1 (4.9–20.7) 7.6 (3.9–14.7) 
EI > 0.3    
Frequency 34.1 (86/252) 32.1 (81/252) 31.8 (68/214) 
OR (CI) 3.1 (2.2–4.5) 3.5 (2.3–5.3) 4.1 (2.7–6.2) 
Occluded sulci    
Frequency 36.9 (24/65) 30.2 (19/63) 25.5 (14/55) 
OR (CI) 4.2 (2.4–7.6) 4.3 (2.1–8.8) 3.3 (1.7-6.4) 
Legend: HcVe = Hydrocephalic ventricular enlargement, EI = Evans Index, OccSul 
= Occluded sulci, n= The number of persons within each CT category with 
corresponding clinical feature of NPH, N= The number of persons within each CT 
category examined for the corresponding clinical feature of NPH. Reference group= 
All persons without radiological features of iNPH. Odds ratios show results from 
multiple binary logistic regressions of each CT feature on outcome adjusting for age 
and gender.  
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This is, to date, the largest population-based study on the prevalence of 
iNPH. According to the results, more than one in twenty, among 80-year-olds 
have signs and symptoms consistent with probable iNPH. Furthermore, 4.5 
% of the total sample, and almost 9 % of 80-year-olds, had hydrocephalic 
ventricular enlargement, i.e. radiological findings consistent with iNPH. This 
finding is important considering that ventricular enlargement might be the 
earliest sign of iNPH.103  
 
If the results of this study are true, an estimated 700,000 persons in the 
United States, and two million persons in Europe might be suffering from 
iNPH. Earlier estimates have shown that less than one in twenty are being 
treated94, 104 and the results from this study further indicate that iNPH is highly 
underdiagnosed and undertreated.    
The most important limitation of this study concerns the diagnosis of probable 
iNPH. The diagnosis was made retrospectively, in a rather crude way, using 
data from interviews and clinical examinations. Although cases were 
diagnosed using criteria from international consensus guidelines, there were 
several important clinical features that were not assessed. Gait disturbance, 
cognitive impairment and urinary incontinence are common among older 
persons and often non-specific. Therefore, data on more detailed and specific 
examinations would have been desirable. However, the diagnostic bluntness 
might have also lead to an underestimation of the prevalence, as some iNPH 
patients might only have subtle symptoms. Furthermore, all cases diagnosed 
with probable iNPH had a rather characteristic CT image, i.e. enlarged 
ventricles disproportional to the subarachnoid space. In addition, the 
association between symptoms of iNPH and CT findings were rather strong.  
Additional limitations of this study include those that pertain to observational 
studies in general. These include issues such as low participation rate and 
possible selection bias. Indeed, these factors might have influenced the 
results. However, a selection bias and a low participation rate would probably 
have led to an underestimation of the prevalence. Another limitation is the 
use of CT. The image quality was not optimal in some of the older scans. 
This is due to the technical standard at the time they were made. MRI might 
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have been somewhat better, but was unavailable. Nevertheless, despite 
several limitations, the results of this study indicate that many older persons 
have clinical and imaging features of iNPH and are in need of further 
evaluations. iNPH is probably more common than previously supposed. 
Given the progressive nature and debilitating symptoms, it is crucial to 
increase the possibilities for early diagnosis and treatment.  
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Paper II  
In this population-based study, WMLs, Hypertension, diabetes, stroke/TIA 
and overweight were more common in cases with hydrocephalic ventricular 
enlargement and suspected iNPH compared to matched controls (Table 6). In 
the regression models, suspected iNPH was associated with moderate to 
severe WMLs, while hydrocephalic ventricular enlargement was related to 
history of hypertension, moderate to severe WMLs, and diabetes (Table 7). 
Among cases with hydrocephalic ventricular enlargement, all but four 
persons (51/55, 93%) had hypertension, diabetes, or WMLs on CT. Of those 
with suspected iNPH, all but two persons (24/26, 92%) had hypertension, 
diabetes, or WMLs on CT.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Paper II 
RISK FACTORS  
HVe (Radiological iNPH) 
Hypertension 
WMLs 
Diabetes 
Odds Ratio (95 % CI) 
2.7 (1.1-6.8) 
6.5 (2.1-20.3) 
4.3 (1.1-16.3) 
Suspected iNPH (Probable iNPH) 
WMLs 
Odds Ratio (95 % CI) 
5.2 (1.1-6.8) 
 
AMONG CASES WITH RADIOLOGICAL  
iNPH, ALL BUT 4 PERSONS, i.e. 97 %  
HAD HYPERTENSION, DIABETES  
OR WMLs 
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Table 6. Frequency WMLs and vascular risk factors in cases with hydrocephalic 
ventricular enlargement and suspected iNPH compared to controls 
 
 
Suspected iNPH 
 
HVe 
Cases (n=26) 
% (n/N) 
Controls (n=130) 
% (n/N) 
Cases (n=55)  
% (n/N) 
Controls (n=275) 
% (n/N) 
Hypertension 42.9 (9/21)  21.2 (25/118) a  45.5 (20/44) 26.9 (64/238) a  
Diabetes 13.0 (3/23) 7.6 (9/118) NS 17.0 (8/47) 8.9 (21/237)*  
Smoking 19.0 (4/21) 30.8 (36/117) NS 40.9 (18/44) 45.7 (107/234) NS 
Stroke/TIA 56.5 (13/23) 24.4 (29/119) a 38.3 (18/47) 21.1 (50/237) a 
CAD 18.2 (4/22) 11.0 (13/118) NS 25.5 (12/47) 24.1 (58/241) NS 
Overweight 60.0 (3/5) 44.8 (43/96) NS 70.4 (19/27) 50.8 (99/195)* 
Moderate-Severe 
WMLs 66.7(16/24) 
17.5 (21/120) b 52.1 (25/48) 13.9 (33/237) b 
 
HVe=Hydrocephalic ventricular enlargement, iNPH=Idiopathic Normal Pressure 
Hydrocephalus, TIA=Transient Ischemic Attack, CAD=Coronary Artery Disease, 
WMLs= White Matter Lesions. 
 a p<0.05, b p<0.001, NS p>0.05, * p<0.1, p-values are results of Pearson chi-square, 
cases vs controls. Data are % (n/N): n=Number of persons with corresponding risk 
factor, N=Number of persons examined for the corresponding risk factor. WMLs 
were graded on the Gothenburg scale, 0-3 (Not present or only mild = 0-1 vs 
moderate-severe=2-3). 
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Table 7. Multivariable analysis of vascular risk factors in hydrocephalic ventricular 
enlargement and suspected iNPH 
 
  
Suspected iNPH (n=26)  HVe (n=55) 
 
OR (95% CI) 
 
p-value 
 
 
 
OR (95% CI) 
 
p-value 
 
Hypertension 
 
2.1 (0.5-8.7) 
 
0.286 
 
 
 
2.7 (1.1-6.8) 
 
0.039 
 
WMLs 
 
5.2 (1.5-17.6) 
 
0.009 
 
 
 
6.5 (2.1-20.3) 
 
0.001 
 
Stroke/TIA 
 
2.3 (0.7-7.8) 
 
0.178 
 
 
 
0.8 (0.2-3.3) 
 
0.741 
 
Diabetes  
 
-  
  
- 
 
 
 
4.3 (1.1-16.3) 
 
0.031 
 
Overweight 
 
-  
 
-  
 
 
 
1.8 (0.6-5.4) 
 
0.293 
HVe=Hydrocephalic ventricular enlargement, iNPH=Idiopathic Normal Pressure 
Hydrocephalus, OR=Odds Ratio, CI=Confidence Interval, WMLs=White Matter 
Lesions. WMLs graded on the Gothenburg scale, 0-3 (Not present or only mild = 0-1 
vs moderate-severe=2-3). OR’s and p-values show results of conditional logistic 
regression models. The model for suspected iNPH included history of hypertension 
WMLs and stroke/TIA. For HVe, the model included History of hypertension, 
WMLs, Stroke/TIA, Diabetes mellitus and Overweight.  
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The results of this study suggest that vascular mechanisms might be involved 
in the pathophysiology of iNPH. The fact that vascular risk factors are 
common in iNPH might also be important from a clinical standpoint. Health 
care professionals ought to be aware of the high occurrence of vascular risk 
factors in iNPH, considering that they are treatable.  
The main strength of this study is the population-based sample. Previous 
investigations regarding the risk factors in iNPH have been made using 
hospital-based samples. These studies might have included more severe 
cases and had a higher risk of selection bias, given that cases and controls 
were selected separately. In the present study, a large representative sample 
was examined, and a nested case-control analysis was performed. Thus, 
cases and controls were obtained from the same population. Furthermore, 
exposure data was collected prospectively from comprehensive clinical 
examinations and the Swedish National Inpatient Register. Nevertheless 
there are several important sources of potential bias that should be 
considered. Similar to the first study in this thesis, there was a diagnostic 
bluntness regarding the cases. This might have led to bias and confounding. 
However, the persons included in this study were not scanned due to 
symptoms or suspicions of iNPH, yet a strong association between imaging 
signs of iNPH and several vascular factors was found. The group with 
hydrocephalic ventricular enlargement should theoretically have been 
subjected to less bias, considering that they were selected solely on the basis 
of imaging findings by blinded observers. Also, the number of cases was 
relatively small. A larger sample would probably have provided more precise 
outcome estimates. Furthermore, the use of CT is an important limitation, in 
particular regarding analysis of WMLs. MRI would have been better. 
Although, it has been suggested that CT might be more specific for detection 
of clinically relevant WMLs.192 Another important limitation is the fact that the 
study design does not allow for causal inference. It is not known whether the 
WMLs cause iNPH, or vice versa. For example, it might be that white matter 
changes in iNPH are not merely due to small vessel disease, but could also 
be caused by CSF stagnation or edema due to iNPH. However, it is not 
particularly common for any single study to, by itself, provide causal 
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evidence. Thus, it is important to view the results in context. When taking into 
consideration that several previous, clinical and animal, studies have 
provided concurring data, the results of this study suggest that vascular 
disease processes are probably involved in the mechanisms underlying 
iNPH.   
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Paper III 
Evans Index ranged between 0.11 and 0.46, in the total sample. The mean 
value was 0.28 (SD 0.04). Descriptive statistics are shown in Table 8. The 
distribution of Evans Index in the total sample is shown in figure 11.  
On average, men had higher values than women, 0.29 vs 0.27 (p<0.001). 
Also, higher age was associated with larger values of Evans Index in age 
groups 70-79 years vs 80 years or older (0.27 vs 0.29, p<0.001). The mean 
value of Evans Index, in men aged 80 years or more was 0.3 (SD 0.03). The 
number of persons with Evans Index > 0.3, in the total sample was 255 (20.6 
%). These findings are shown in table 9 and figure 12. The mean value of 
Evans Index among those with hydrocephalic ventricular enlargement (n=55) 
was 0.36 (SD 0.04).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Paper III 
EVANS INDEX 
MEAN VALUES OF EVANS INDEX BY AGE GROUPS 
70-74 years 75-79 years 80-84 years 85 + years 
 
More than 1 in 5 individuals above 
the age of 70 fulfilled current criteria 
for ventricular enlargement 
 
 
 
 
THE FREQUENCY OF  
EVANS INDEX > 0.3  
IN THOSE AGED  
85 YEARS OR MORE 
 
 
 
 
THE FREQUENCY OF  
EVANS INDEX > 0.3  
IN THE TOTAL SAMPLE 
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Figure 11. Distribution of values of Evans Index in the study population 
 
 
 
 
 
 
 
Daniel Jaraj 
69 
 
 
Figure 12. Values of Evans Index by age groups and sex 
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Table 8. Descriptive statistics for Evans Index in a population-based sample of 1235 
men and women aged 70 years or more 
Descriptive variable  Value (Total sample n=1235) 
Mean 0.275 
95 % CI 0.273-0.277 
Median 0.270 
Interquartile range 0.05 
Std. Deviation 0.04 
Minimum-Maximum value of EI 0.11-0.46 
Percentiles  
5th 0.22 
10th 0.23 
25th 0.25 
50th 0.27 
75th 0.30 
90th 0.33 
95th 0.35 
CI= Confidence Interval, Std. Deviation= Standard Deviation, EI=Evans Index.  
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Table 9. Mean values of Evans Index and frequency of values higher than 0.3 by sex 
and age group in a population based sample of 1235 men and women 
 Age groups (years)  
 70-74 75-79 80-84 85+ 
Total 
sample 
Mean Evans Index  
Men (SD) 0.28 (0.04) 0.29 (0.04) 0.30 (0.03) 0.31 (0.05) 0.29 (0.05) 
Women (SD) 0.26 (0.03) 0.27 (0.04) 0.28 (0.04) 0.29 (0.05) 0.27 (0.04) 
Total (SD) 0.27 (0.03) 0.27 (0.04) 0.28 (0.04) 0.30 (0.05) 0.28 (0.04) 
Evans Index >0.3 
Men % (n) 23.7 (45) 22.2 (4) 42.5 (17) 48.3 (42) 32.2 (108) 
Women % (n) 10.0 (52) 9.4 (10) 21.4 (18) 35.1 (67) 16.3 (147) 
Total % (n) 13.7 (97) 11.3 (14) 28.2 (35) 39.2 (109) 20.6 (255) 
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This is the first population-based study to report reference values on Evans 
Index. Evans Index is extensively used in both research and clinical practice, 
despite the fact that normal values in adults are not precisely known. A 
correct, and early diagnosis of iNPH is crucial considering the progressive 
nature of the disorder. The results of this study indicate that the current cut-
off criterion, of 0.3, has a low specificity. The mean value of Evans Index, in 
the total sample was close to what is currently considered pathological. Also, 
more than one fifth of the study population would be classified as having 
ventricular enlargement if the definition of Evans Index > 0.3 is used. 
Moreover, men aged 80 years or more, had on average, values equal to or 
higher than 0.3.  
One of the main limitations of this study is the fact that Evans Index was 
measured by non-radiologists. However, considering that Evans Index is a 
simple linear measure based on rather obvious anatomical structures, it could 
reasonable to suppose that even non-specialists, i.e. persons with basic 
training in neurology and neuroradiology, can perform the measurement 
correctly. Other potential sources of bias may be unbalance in the data and 
possible cohort effects. In addition, it is important to mention the possibility of 
selection bias. Among those in the original sample, many did not undergo CT 
imaging. This might have affected the results. However, when comparing CT-
participants vs non-CT-participants, only small differences were noted.   
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Paper IV 
Crude 5-year mortality was higher in those with probable iNPH, compared to 
individuals without iNPH (87.5 % vs 19.1 %, p<0.001). The crude five-year 
mortality and adjusted hazard ratios for each group is shown in table 10. 
Figure 13 shows the Kaplan-Meier survival curves for each group. Mortality 
was increased in those with probable iNPH (n=24), and in the total group with 
hydrocephalic ventricular enlargement (n=53) in Cox proportional hazard 
models. There was no significant difference in mortality between those with 
possible iNPH/asymptomatic hydrocephalic ventricular enlargement (n=29) 
and those without imaging signs of iNPH.  
The risk of dementia during follow-up, among those with possible iNPH or 
asymptomatic hydrocephalic ventricular enlargement (n=29), was also 
examined. In total, 40.0 % of those with possible iNPH or asymptomatic 
hydrocephalic ventricular enlargement developed dementia, compared to 
20.6 % of those without (p=0.019). The estimated hazard ratio for dementia, 
adjusted for baseline age, sex and cohort, was 2.8 (95% CI: 1.5-5.2). Among 
all those with hydrocephalic ventricular enlargement (n=53), 68 % (n=36) had 
dementia at baseline, or developed dementia during follow-up (adjusted odds 
ratio 4.9; 95% CI: 2.5-9.6, compared to those without imaging findings of 
iNPH). 
Regarding the progression of symptoms, 45 % of those with possible iNPH or 
asymptomatic hydrocephalic ventricular enlargement developed probable 
iNPH during follow-up. Only two persons (3.8 %) with hydrocephalic 
ventricular enlargement remained asymptomatic throughout follow-up.  
 
 
 
 
 
 Paper IV 
LONG-TERM OUTCOME 
5-YEAR MORTALITY 
THE HAZARD RATIO FOR DEVELOPING DEMENTIA
DURING FOLLOW-UP IN THOSE WITH POSSIBLE iNPH  
OR ASYMPTOMATIC HYDROCEPHALIC VENTRICULAR 
ENLARGEMENT 
68 % OF THOSE WITH HYDROCEPHALIC VENTRICULAR 
ENLARGEMENT HAD DEMENTIA AT BASELINE OR AT 
THE END OF FOLLOW-UP: 
ADJUSTED ODDS RATIO 4.9 (2.5 - 9.6) 
OF THOSE WITH HYDROCEPHALIC VENTRICULAR 
ENLARGEMENT, ONLY TWO PERSONS (3.8 %) REMAINED 
ASYMPTOMATIC DURING FOLLOW-UP 
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Table 10. Mortality among study participants 
  Hydrocephalic ventricular enlargement (HVe) 
 Individuals 
without iNPH 
n=1180 
Probable iNPH 
n=24 
Possible iNPH & 
Asymptomatic 
HVe n=29 
All cases 
with HVe 
n=53 
 
Unadjusted five-
year mortality, 
% (n) 
 
19.1 (225) 
 
87.5 (21)*** 
 
27.6 (8) ns 
 
54.7 (29)*** 
Adjusted HR (95 
% CI) 
- 3.8 (2.4-5.8) 1.2 (0.7-1.8) 1.9 (1.4-2.5) 
Legend: iNPH=idiopathic Normal Pressure Hydrocephalus, HVe=Hydrocephalic 
ventricular enlargement, HR=Hazard ratio, *** p<0.001, ns: p=0.251, p-values show 
results of Pearson Chi-square test compared to individuals without iNPH. Hazard 
ratios were estimated using Cox proportional hazard models including age at 
baseline, sex and study cohort. The group with possible iNPH and asymptomatic 
hydrocephalic ventricular enlargement included 4 persons who had hydrocephalic 
ventricular enlargement but missing data regarding symptoms of iNPH. 
 
 
 
 
Figure 13. Unadjusted survival curves (Kaplan-Meier), comparing individuals 
without iNPH (Reference group), persons with possible iNPH (also including 
those with asymptomatic hydrocephalic ventricular enlargement and missing 
clinical data) (p=0.284), and individuals with probable iNPH (p<0.001). Groups 
were compared using the Log rank test.  
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According to the results of this study, untreated individuals with signs and 
symptoms of iNPH have a substantially increased risk of mortality and 
dementia. Furthermore, almost all persons with imaging signs of iNPH 
developed dementia or other symptoms of iNPH. These findings indicate that 
imaging signs of iNPH are important markers for cognitive impairment and 
neurological disability. The results of this study suggest that clinical and 
radiological signs of iNPH are associated with a markedly poor prognosis 
with a high risk of death and dementia among untreated persons. 
The results of this study also suggest that radiological signs of iNPH might 
precede clinical symptoms. This has previously been indicated by a study 
that examined six cases.103 If it is true that radiological signs are the first to 
develop, then current diagnostic criteria might only capture individuals at a 
later stage when the disorder has manifested with more severe symptoms. 
Therefore, the results of this study might also have implications regarding the 
diagnosis of iNPH.       
There are no previous epidemiological studies on long-term outcome in iNPH. 
Previous studies have mainly used hospital-based samples and there is very 
little data on the natural course. Furthermore, the risk of dementia and 
progression of symptoms over time is not precisely known.  
Main strengths of this study include the population-based sample, 
comprehensive examinations and duration of follow-up. There are, however, 
also several important limitations that should be discussed. As described 
previously, the diagnostic uncertainty regarding iNPH is important to 
consider. Although this may have influenced the validity of the study, it is also 
reasonable to suppose that there might have been less bias regarding the 
associations between imaging signs of iNPH and outcomes. The reason for 
this is that those with hydrocephalic ventricular enlargement were diagnosed 
by a consultant neuroradiologist, unaware of clinical data.  Therefore, results 
of this study suggest that imaging findings of iNPH are associated with a poor 
prognosis regardless of symptoms. Other limitations, that have also been 
discussed earlier, include unbalance in the data, possible cohort effects and 
small number of cases. The group with possible iNPH and asymptomatic 
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hydrocephalic ventricular enlargement (n=29) did not have a significantly 
increased mortality. These persons were, on average, younger and part of 
the more recent cohorts, thus having less follow-up time. It is plausible that 
significant differences might have been detected using a larger sample with 
longer follow-up. Cases were diagnosed with CT, and MRI would probably 
have been somewhat better. However, this was not available at the time of 
baseline examinations. Small obstructive lesions can be missed on CT. 
Nevertheless, it can be argued that CT imaging allows for an overall sufficient 
assessment of the ventricles and high convexity sulci.  
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6 CONCLUSIONS AND FUTURE 
PERSPECTIVES 
 
 
iNPH is probably more common than previously supposed. Furthermore, a 
large number of older persons have imaging features consistent with iNPH. 
This finding is important considering that radiological features might be an 
early sign of iNPH.  
Many elderly are in need of further evaluations. However, despite being a 
treatable disorder, the number of persons being diagnosed and treated is 
likely far less than the actual number of person suffering from iNPH. 
Considering that life expectancy is rising, the number of patients with iNPH 
might also increase. There is a need for future studies to improve diagnosis 
and selection of candidates for shunt surgery. 
Vascular factors, such as cerebral WMLs, hypertension and diabetes are 
rather strongly associated with iNPH. The findings indicate that vascular 
disease mechanisms are involved in the pathophysiology. Considering also 
earlier data, a causal association may be supposed. Clinicians ought to be 
aware of the high occurrence of vascular diseases in iNPH since concurrent 
management of risk factors is important. The findings may also have 
importance from a perspective of preventive measures. Future studies should 
aim to further elucidate the role of vascular mechanisms in iNPH. This might 
not only improve understanding of the pathophysiology but also provide 
insight into disease features that might be of diagnostic importance. It is also 
important to learn more about potential causes in order to improve treatment. 
Also, future investigations regarding other mechanisms including non-
vascular risk factors would be of value. 
Mean values of Evans Index, among older persons in the general population, 
are higher than previously reported. Current criteria for ventricular 
enlargement might capture as many as one in five, of those aged 70 years or 
more. Thus, the current cut-off value of 0.3 probably has a low specificity for 
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the diagnosis of iNPH. Persons with hydrocephalic ventricular enlargement 
had, on average, values above the 95th percentile. However, it is difficult to 
determine diagnostic cut-off values. For example, it is not known whether or 
not persons with Evans Index below 0.3 could still have iNPH. Considering 
that ventricle size does seem not predict outcome after shunt surgery, more 
advanced imaging such as volumetric assessment of the ventricles, 
subarachnoid space and cortical thickness might be of greater value. Given 
the risks of shunt surgery, a correct diagnosis of iNPH is crucial. However, 
previous attempts to predict shunt response based on various hydrodynamic 
characteristics have so far been rather futile. Further research on clinical 
variables and other imaging features, such as white matter changes, blood 
flow and metabolism might add more knowledge and insight. Also, 
considering the high degree of overlap between iNPH and other 
neurodegenerative conditions, future studies on diagnostic measures should 
include not only iNPH patients and healthy controls, but also patients with 
other diagnoses such as Alzheimer’s disease and vascular dementia. It is 
also important for future studies to have adequate power given the 
heterogeneity of iNPH.  
Untreated individuals who fulfill criteria for probable iNPH have substantial 
excess mortality. Considering these findings, individuals with signs and 
symptoms of iNPH should be thoroughly evaluated and treated without delay 
if the diagnosis is confirmed. Furthermore, persons with radiological signs of 
iNPH appear to have a very high risk of developing dementia or other 
symptoms. Radiological signs are therefore probably more important than 
previously thought. It remains to be elucidated whether pre-symptomatic 
iNPH should be treated. Additional epidemiological studies, using population-
based data, are needed in the field. However, given the estimated prevalence 
of iNPH, even relatively large samples would likely yield a somewhat small 
number of cases. One way to circumvent this problem might be to merge 
population data from several centers. 
 81 
Epidemiology of Normal Pressure Hydrocephalus 
82 
ACKNOWLEDGEMENTS 
 
 
I would like to express my most sincere gratitude to all of those who have 
offered their help, encouragement and kind support.  
 
I wish to thank my supervisors. Needless to say, without whom this thesis 
would not exist.  
 
Ingmar Skoog, thank you for taking me on as your PhD student and 
embracing me into your research group. Your devotion and endless curiosity 
has been a genuine source of inspiration. Among many things, you taught me 
the value of patience and precision in research. I owe you my deepest 
gratitude.  
 
Carsten WikkelsØ, you took me on as a medical student and trusted me with 
meaningful work. For this I am forever grateful. Your creativeness, level of 
perception and constant drive has been an inspiration. Thank you for 
showing me what true leadership is like.  
 
Katrin Rabiei, colleague, co-author, and friend. You taught me how to work 
hard, be passionate and still have fun. (As a medical student, you also taught 
me the meaning of the surgeons promise). Thank you for all your support and 
kind friendship.  
 
Tina Jacobsson, I cannot thank you enough for everything that you have 
done. I feel that this work would not be possible without you. To say that your 
contributions have been invaluable would be an understatement. You helped 
me feel at home in the group, and your professionalism has been an 
inspiration from day one. Thank you so much for everything. 
 
Cecilia Mellqvist, thank you for all your help. You also showed me what it 
means to be professional and devoted. I wish to express my most sincere 
appreciation for all of your contributions to this research. 
 
Tom Marlow, thank you for your patience, calmness and keen-sightedness. 
This work would not have been possible without you. Our discussions on 
statistics and study design have been one of the more joyful parts of this 
work.  
 
Thank you, to all my co-authors: Christer Jensen, Svante Östling and Simon 
Agerskov. 
 
 83 
Kristoffer Bäckman, thank you for all your help. Working with you has been a 
constant enjoyment. I treasure our many discussions on data sciences and 
truly admire your high level of knowledge. 
 
Valter Sundh and Erik Joas, thank you for teaching me about statistics and 
allowing me to ask all the senseless questions. Having you as colleagues has 
been a great satisfaction.  
 
Mikael Edsbagge, thank you so much for giving me a place in the neurology 
clinic. Thank you also for teaching me about hydrocephalus and general 
neurology, and being such a fantastic mentor. You are, by far, the best boss I 
have ever had.  
 
I also want to thank the best nurses in the world, Christel Olivefors, Tove 
Bulic Rasmussen and Eva Niemi. It was a delight to work with you and 
experience the high level care that you provide each patient. Also, thank you, 
Gunilla Ahl-Börjesson, for all you kindness, support and help.  
 
To those who are not mentioned, please forgive me, and know that I am 
grateful to everyone in the hydrocephalus research unit and neuropsychiatric 
epidemiology research group.  
 
I would like to thank my dear friend and main man, Hasif Hakim. Without you, 
I wouldn’t even have the “M” in the M.D.  
 
Slutligen, vill jag tacka min familj. Min mamma Katalin, min pappa Janos och 
min kära bror David. Ni har gett mig allt. Genom hela min uppväxt har jag 
överväldigats av den varmaste kärlek man kan tänka sig. Min älskade 
storebror David, som är den smartaste och mest perfekta förebild som finns. 
Inget av detta vore möjligt utan er.  
 
Min fantastiska Rebecka, och hennes underbara familj, Charlotte, Staffan, 
Henrik, Magrethe, Ulrika, Mathias, Lovisa, Markus, Nils-Gunnar och Greta, 
samt Jan-Erik och Ylva. Tack för allt ni har gett mig genom åren.  
 
Min underbara, älskade, vackra Rebecka. Vi har vuxit upp tillsammans och 
du har lärt mig så mycket, stöttat mig och alltid funnits vid min sida. Jag har 
det aldrig så roligt som när jag är med dig. Ingen är klokare än du, och jag 
kan inte ens beskriva den tacksamhet jag känner.  
 
Epidemiology of Normal Pressure Hydrocephalus 
84 
REFERENCES 
 
1.Relkin N, Marmarou A, Klinge P, Bergsneider M, Black PM. Diagnosing 
idiopathic normal-pressure hydrocephalus. Neurosurgery 2005;57:S4-16; 
discussion ii-v. 
 
2.Mori K, Shimada J, Kurisaka M, Sato K, Watanabe K. Classification of 
hydrocephalus and outcome of treatment. Brain & development 1995;17:338-
348. 
 
3.Gallia GL, Rigamonti D, Williams MA. The diagnosis and treatment of 
idiopathic normal pressure hydrocephalus. Nature clinical practice Neurology 
2006;2:375-381. 
 
4.Kiefer M, Unterberg A. The differential diagnosis and treatment of normal-
pressure hydrocephalus. Deutsches Arzteblatt international 2012;109:15-25; 
quiz 26. 
 
5.Hakim S, Adams RD. The special clinical problem of symptomatic 
hydrocephalus with normal cerebrospinal fluid pressure. Observations on 
cerebrospinal fluid hydrodynamics. Journal of the neurological sciences 
1965;2:307-327. 
 
6.Adams RD, Fisher CM, Hakim S, Ojemann RG, Sweet WH. 
SYMPTOMATIC OCCULT HYDROCEPHALUS WITH "NORMAL" 
CEREBROSPINAL-FLUID PRESSURE.A TREATABLE SYNDROME. The 
New England journal of medicine 1965;273:117-126. 
 
7.Wallenstein MB, McKhann GM, 2nd. Salomon Hakim and the discovery of 
normal-pressure hydrocephalus. Neurosurgery 2010;67:155-159; discussion 
159. 
 
8.Hashimoto M, Ishikawa M, Mori E, Kuwana N. Diagnosis of idiopathic 
normal pressure hydrocephalus is supported by MRI-based scheme: a 
prospective cohort study. Cerebrospinal fluid research 2010;7:18. 
 
9.Graff-Radford NR. Normal pressure hydrocephalus. Neurologic clinics 
2007;25:809-832, vii-viii. 
 85 
 
10.Malm J, Graff-Radford NR, Ishikawa M, et al. Influence of comorbidities in 
idiopathic normal pressure hydrocephalus - research and clinical care. A 
report of the ISHCSF task force on comorbidities in INPH. Fluids and barriers 
of the CNS 2013;10:22. 
 
11.Stolze H, Kuhtz-Buschbeck JP, Drucke H, Johnk K, Illert M, Deuschl G. 
Comparative analysis of the gait disorder of normal pressure hydrocephalus 
and Parkinson's disease. Journal of neurology, neurosurgery, and psychiatry 
2001;70:289-297. 
 
12.Stolze H, Kuhtz-Buschbeck JP, Drucke H, et al. Gait analysis in idiopathic 
normal pressure hydrocephalus--which parameters respond to the CSF tap 
test? Clinical neurophysiology : official journal of the International Federation 
of Clinical Neurophysiology 2000;111:1678-1686. 
 
13.Blomsterwall E, Svantesson U, Carlsson U, Tullberg M, Wikkelso C. 
Postural disturbance in patients with normal pressure hydrocephalus. Acta 
neurologica Scandinavica 2000;102:284-291. 
 
14.Wikkelso C, Blomsterwall E, Frisen L. Subjective visual vertical and 
Romberg's test correlations in hydrocephalus. Journal of neurology 
2003;250:741-745. 
 
15.L. Pantoni DI, A. Wallin, ed. The Matter of White Matter, Clinical and 
Pathophysiological Aspects of White Matter Disease Related to Cognitive 
Decline and Vascular Dementia: Academic Pharmaceutical Productions 
2000. 
 
16.Mori E, Ishikawa M, Kato T, et al. Guidelines for management of idiopathic 
normal pressure hydrocephalus: second edition. Neurologia medico-
chirurgica 2012;52:775-809. 
 
17.Ogino A, Kazui H, Miyoshi N, et al. Cognitive impairment in patients with 
idiopathic normal pressure hydrocephalus. Dementia and geriatric cognitive 
disorders 2006;21:113-119. 
18.Hellstrom P, Edsbagge M, Archer T, Tisell M, Tullberg M, Wikkelso C. The 
neuropsychology of patients with clinically diagnosed idiopathic normal 
Epidemiology of Normal Pressure Hydrocephalus 
86 
pressure hydrocephalus. Neurosurgery 2007;61:1219-1226; discussion 1227-
1218. 
 
19.Hellstrom P, Klinge P, Tans J, Wikkelso C. The neuropsychology of iNPH: 
findings and evaluation of tests in the European multicentre study. Clinical 
neurology and neurosurgery 2012;114:130-134. 
 
20.Jonas S, Brown J. Neurogenic bladder in normal pressure hydrocephalus. 
Urology 1975;5:44-50. 
 
21.Sakakibara R, Kanda T, Sekido T, et al. Mechanism of bladder 
dysfunction in idiopathic normal pressure hydrocephalus. Neurourology and 
urodynamics 2008;27:507-510. 
 
22.Brodbelt A, Stoodley M. CSF pathways: a review. British journal of 
neurosurgery 2007;21:510-520. 
 
23.Cutler RW, Page L, Galicich J, Watters GV. Formation and absorption of 
cerebrospinal fluid in man. Brain : a journal of neurology 1968;91:707-720. 
 
24.Kapoor KG, Katz SE, Grzybowski DM, Lubow M. Cerebrospinal fluid 
outflow: an evolving perspective. Brain research bulletin 2008;77:327-334. 
 
25.Arthur C. Guyton JEH. Textbook of Medical Physiology, 11th ed: Elsevier 
Saunders, 2006. 
 
26.Abbott NJ. Evidence for bulk flow of brain interstitial fluid: significance for 
physiology and pathology. Neurochemistry international 2004;45:545-552. 
 
27.Brinker T, Stopa E, Morrison J, Klinge P. A new look at cerebrospinal fluid 
circulation. Fluids and barriers of the CNS 2014;11:10. 
 
28.Edsbagge M, Tisell M, Jacobsson L, Wikkelso C. Spinal CSF absorption 
in healthy individuals. American journal of physiology Regulatory, integrative 
and comparative physiology 2004;287:R1450-1455. 
29.Erlich SS, McComb JG, Hyman S, Weiss MH. Ultrastructural morphology 
of the olfactory pathway for cerebrospinal fluid drainage in the rabbit. Journal 
of neurosurgery 1986;64:466-473. 
 
 87 
30.Silver I, Kim C, Mollanji R, Johnston M. Cerebrospinal fluid outflow 
resistance in sheep: impact of blocking cerebrospinal fluid transport through 
the cribriform plate. Neuropathology and applied neurobiology 2002;28:67-74. 
 
31.Xie L, Kang H, Xu Q, et al. Sleep Drives Metabolite Clearance from the 
Adult Brain. Science 2013;342:373-377. 
 
32.Ren Z, Iliff JJ, Yang L, et al. 'Hit & Run' model of closed-skull traumatic 
brain injury (TBI) reveals complex patterns of post-traumatic AQP4 
dysregulation. Journal of cerebral blood flow and metabolism : official journal 
of the International Society of Cerebral Blood Flow and Metabolism 
2013;33:834-845. 
 
33.Iliff JJ, Nedergaard M. Is there a cerebral lymphatic system? Stroke; a 
journal of cerebral circulation 2013;44:S93-95. 
 
34.Skjolding AD, Rowland IJ, Sogaard LV, Praetorius J, Penkowa M, Juhler 
M. Hydrocephalus induces dynamic spatiotemporal regulation of aquaporin-4 
expression in the rat brain. Cerebrospinal fluid research 2010;7:20. 
 
35.Rekate HL. The definition and classification of hydrocephalus: a personal 
recommendation to stimulate debate. Cerebrospinal fluid research 2008;5:2. 
 
36.DeLand FH, James AE, Jr., Ladd DJ, Konigsmark BW. Normal pressure 
hydrocephalus: a histologic study. American journal of clinical pathology 
1972;58:58-63. 
 
37.Bech RA, Waldemar G, Gjerris F, Klinken L, Juhler M. Shunting effects in 
patients with idiopathic normal pressure hydrocephalus; correlation with 
cerebral and leptomeningeal biopsy findings. Acta neurochirurgica 
1999;141:633-639. 
 
38.Boon AJ, Tans JT, Delwel EJ, et al. Dutch normal-pressure hydrocephalus 
study: prediction of outcome after shunting by resistance to outflow of 
cerebrospinal fluid. Journal of neurosurgery 1997;87:687-693. 
 
39.May C, Kaye JA, Atack JR, Schapiro MB, Friedland RP, Rapoport SI. 
Cerebrospinal fluid production is reduced in healthy aging. Neurology 
1990;40:500-503. 
Epidemiology of Normal Pressure Hydrocephalus 
88 
 
40.Albeck MJ, Skak C, Nielsen PR, Olsen KS, Borgesen SE, Gjerris F. Age 
dependency of resistance to cerebrospinal fluid outflow. Journal of 
neurosurgery 1998;89:275-278. 
 
41.Malm J, Jacobsson J, Birgander R, Eklund A. Reference values for CSF 
outflow resistance and intracranial pressure in healthy elderly. Neurology 
2011;76:903-909. 
 
42.Marmarou A, Bergsneider M, Klinge P, Relkin N, Black PM. The value of 
supplemental prognostic tests for the preoperative assessment of idiopathic 
normal-pressure hydrocephalus. Neurosurgery 2005;57:S17-28; discussion 
ii-v. 
 
43.Raftopoulos C, Deleval J, Chaskis C, et al. Cognitive recovery in idiopathic 
normal pressure hydrocephalus: a prospective study. Neurosurgery 
1994;35:397-404; discussion 404-395. 
 
44.Eide PK, Sorteberg W. Diagnostic intracranial pressure monitoring and 
surgical management in idiopathic normal pressure hydrocephalus: a 6-year 
review of 214 patients. Neurosurgery 2010;66:80-91. 
 
45.Stephensen H, Andersson N, Eklund A, Malm J, Tisell M, Wikkelso C. 
Objective B wave analysis in 55 patients with non-communicating and 
communicating hydrocephalus. Journal of neurology, neurosurgery, and 
psychiatry 2005;76:965-970. 
 
46.Casmiro M, D'Alessandro R, Cacciatore FM, Daidone R, Calbucci F, 
Lugaresi E. Risk factors for the syndrome of ventricular enlargement with gait 
apraxia (idiopathic normal pressure hydrocephalus): a case-control study. 
Journal of neurology, neurosurgery, and psychiatry 1989;52:847-852. 
 
47.Graff-Radford NR, Godersky JC. Idiopathic normal pressure 
hydrocephalus and systemic hypertension. Neurology 1987;37:868-871. 
 
48.Jacobs L. Diabetes mellitus in normal pressure hydrocephalus. Journal of 
neurology, neurosurgery, and psychiatry 1977;40:331-335. 
 
 89 
49.Krauss JK, Regel JP, Vach W, Droste DW, Borremans JJ, Mergner T. 
Vascular risk factors and arteriosclerotic disease in idiopathic normal-
pressure hydrocephalus of the elderly. Stroke; a journal of cerebral circulation 
1996;27:24-29. 
 
50.Eide PK, Pripp AH. Increased prevalence of cardiovascular disease in 
idiopathic normal pressure hydrocephalus patients compared to a population-
based cohort from the HUNT3 survey. Fluids and Barriers of the CNS 
2014;11:19. 
 
51.Graff-Radford NR, Knopman DS, Penman AD, Coker LH, Mosley TH. Do 
systolic BP and pulse pressure relate to ventricular enlargement? European 
journal of neurology : the official journal of the European Federation of 
Neurological Societies 2013;20:720-724. 
 
52.Ritter S, Dinh TT. Progressive postnatal dilation of brain ventricles in 
spontaneously hypertensive rats. Brain research 1986;370:327-332. 
 
53.Di Rocco C, Pettorossi VE, Caldarelli M, Mancinelli R, Velardi F. 
Experimental hydrocephalus following mechanical increment of 
intraventricular pulse pressure. Experientia 1977;33:1470-1472. 
 
54.Akai K, Uchigasaki S, Tanaka U, Komatsu A. Normal pressure 
hydrocephalus. Neuropathological study. Acta pathologica japonica 
1987;37:97-110. 
 
55.Pantoni L, Garcia JH. Pathogenesis of leukoaraiosis: a review. Stroke; a 
journal of cerebral circulation 1997;28:652-659. 
 
56.Bradley WG, Jr., Whittemore AR, Watanabe AS, Davis SJ, Teresi LM, 
Homyak M. Association of deep white matter infarction with chronic 
communicating hydrocephalus: implications regarding the possible origin of 
normal-pressure hydrocephalus. AJNR American journal of neuroradiology 
1991;12:31-39. 
 
57.Krauss JK, Regel JP, Vach W, et al. White matter lesions in patients with 
idiopathic normal pressure hydrocephalus and in an age-matched control 
group: a comparative study. Neurosurgery 1997;40:491-495; discussion 495-
496. 
Epidemiology of Normal Pressure Hydrocephalus 
90 
 
58.O'Brien JT, Erkinjuntti T, Reisberg B, et al. Vascular cognitive impairment. 
The Lancet Neurology 2003;2:89-98. 
 
59.Tullberg M, Hultin L, Ekholm S, Mansson JE, Fredman P, Wikkelso C. 
White matter changes in normal pressure hydrocephalus and Binswanger 
disease: specificity, predictive value and correlations to axonal degeneration 
and demyelination. Acta Neurol Scand 2002;105:417-426. 
 
60.Tullberg M, Jensen C, Ekholm S, Wikkelso C. Normal pressure 
hydrocephalus: vascular white matter changes on MR images must not 
exclude patients from shunt surgery. AJNR American journal of 
neuroradiology 2001;22:1665-1673. 
 
61.Momjian S, Owler BK, Czosnyka Z, Czosnyka M, Pena A, Pickard JD. 
Pattern of white matter regional cerebral blood flow and autoregulation in 
normal pressure hydrocephalus. Brain : a journal of neurology 2004;127:965-
972. 
 
62.Ziegelitz D, Starck G, Kristiansen D, et al. Cerebral perfusion measured by 
dynamic susceptibility contrast MRI is reduced in patients with idiopathic 
normal pressure hydrocephalus. Journal of magnetic resonance imaging : 
JMRI 2014;39:1533-1542. 
 
63.Owler BK, Pickard JD. Normal pressure hydrocephalus and cerebral blood 
flow: a review. Acta neurologica Scandinavica 2001;104:325-342. 
 
64.Hertel F, Walter C, Schmitt M, et al. Is a combination of Tc-SPECT or 
perfusion weighted magnetic resonance imaging with spinal tap test helpful in 
the diagnosis of normal pressure hydrocephalus? Journal of neurology, 
neurosurgery, and psychiatry 2003;74:479-484. 
 
65.Kimura M, Tanaka A, Yoshinaga S. Significance of periventricular 
hemodynamics in normal pressure hydrocephalus. Neurosurgery 
1992;30:701-704; discussion 704-705. 
 
66.Krauss JK, Droste DW, Vach W, et al. Cerebrospinal fluid shunting in 
idiopathic normal-pressure hydrocephalus of the elderly: effect of 
 91 
periventricular and deep white matter lesions. Neurosurgery 1996;39:292-
299; discussion 299-300. 
 
67.Tisell M, Tullberg M, Hellstrom P, Edsbagge M, Hogfeldt M, Wikkelso C. 
Shunt surgery in patients with hydrocephalus and white matter changes. 
Journal of neurosurgery 2011;114:1432-1438. 
 
68.Johansson E, Ambarki K, Birgander R, Bahrami N, Eklund A, Malm J. 
Cerebral microbleeds in idiopathic normal pressure hydrocephalus. Fluids 
and barriers of the CNS 2016;13:4. 
 
69.Alperin N, Oliu CJ, Bagci AM, et al. Low-dose acetazolamide reverses 
periventricular white matter hyperintensities in iNPH. Neurology 
2014;82:1347-1351. 
 
70.Ivkovic M, Reiss-Zimmermann M, Katzen H, et al. MRI assessment of the 
effects of acetazolamide and external lumbar drainage in idiopathic normal 
pressure hydrocephalus. Fluids and barriers of the CNS 2015;12:9. 
 
71.Vorstrup S, Henriksen L, Paulson OB. Effect of acetazolamide on cerebral 
blood flow and cerebral metabolic rate for oxygen. The Journal of clinical 
investigation 1984;74:1634-1639. 
 
72.Okazawa H, Yamauchi H, Sugimoto K, Toyoda H, Kishibe Y, Takahashi 
M. Effects of acetazolamide on cerebral blood flow, blood volume, and 
oxygen metabolism: a positron emission tomography study with healthy 
volunteers. Journal of cerebral blood flow and metabolism : official journal of 
the International Society of Cerebral Blood Flow and Metabolism 
2001;21:1472-1479. 
 
73.Krefft TA, Graff-Radford NR, Lucas JA, Mortimer JA. Normal pressure 
hydrocephalus and large head size. Alzheimer disease and associated 
disorders 2004;18:35-37. 
 
 
74.Bradley WG, Safar FG, Furtado C, Ord J, Alksne JF. Increased 
intracranial volume: a clue to the etiology of idiopathic normal-pressure 
hydrocephalus? AJNR American journal of neuroradiology 2004;25:1479-
1484. 
Epidemiology of Normal Pressure Hydrocephalus 
92 
 
75.Bradley WG, Jr., Bahl G, Alksne JF. Idiopathic normal pressure 
hydrocephalus may be a "two hit" disease: benign external hydrocephalus in 
infancy followed by deep white matter ischemia in late adulthood. Journal of 
magnetic resonance imaging : JMRI 2006;24:747-755. 
 
76.Bradley WG, Jr. CSF Flow in the Brain in the Context of Normal Pressure 
Hydrocephalus. AJNR American journal of neuroradiology 2015;36:831-838. 
 
77.Wilson RK, Williams MA. Evidence that congenital hydrocephalus is a 
precursor to idiopathic normal pressure hydrocephalus in only a subset of 
patients. Journal of neurology, neurosurgery, and psychiatry 2007;78:508-
511. 
 
78.Koivisto AM, Alafuzoff I, Savolainen S, et al. Poor cognitive outcome in 
shunt-responsive idiopathic normal pressure hydrocephalus. Neurosurgery 
2013;72:1-8;discussion 8. 
 
79.Kapaki EN, Paraskevas GP, Tzerakis NG, et al. Cerebrospinal fluid tau, 
phospho-tau181 and beta-amyloid1-42 in idiopathic normal pressure 
hydrocephalus: a discrimination from Alzheimer's disease. European journal 
of neurology : the official journal of the European Federation of Neurological 
Societies 2007;14:168-173. 
 
80.Leinonen V, Koivisto AM, Alafuzoff I, et al. Cortical brain biopsy in long-
term prognostication of 468 patients with possible normal pressure 
hydrocephalus. Neuro-degenerative diseases 2012;10:166-169. 
 
81.Silverberg GD, Mayo M, Saul T, Rubenstein E, McGuire D. Alzheimer's 
disease, normal-pressure hydrocephalus, and senescent changes in CSF 
circulatory physiology: a hypothesis. The Lancet Neurology 2003;2:506-511. 
 
82.Silverberg GD, Levinthal E, Sullivan EV, et al. Assessment of low-flow 
CSF drainage as a treatment for AD: results of a randomized pilot study. 
Neurology 2002;59:1139-1145. 
83.Silverberg GD, Mayo M, Saul T, Fellmann J, Carvalho J, McGuire D. 
Continuous CSF drainage in AD: results of a double-blind, randomized, 
placebo-controlled study. Neurology 2008;71:202-209. 
 
 93 
84.Jeppsson A, Zetterberg H, Blennow K, Wikkelso C. Idiopathic normal-
pressure hydrocephalus: pathophysiology and diagnosis by CSF biomarkers. 
Neurology 2013;80:1385-1392. 
 
85.Graff-Radford NR. Alzheimer CSF biomarkers may be misleading in 
normal-pressure hydrocephalus. Neurology 2014;83:1573-1575. 
 
86.Laitera T, Sarajarvi T, Haapasalo A, et al. Increased gamma-secretase 
activity in idiopathic normal pressure hydrocephalus patients with beta-
amyloid pathology. PloS one 2014;9:e93717. 
 
87.Pyykkö OT, Helisalmi S, Koivisto AM, et al. APOE4 predicts amyloid-β in 
cortical brain biopsy but not idiopathic normal pressure hydrocephalus. 
Journal of Neurology, Neurosurgery & Psychiatry 2012;83:1119-1124. 
 
88.Savolainen S, Laakso MP, Paljarvi L, et al. MR imaging of the 
hippocampus in normal pressure hydrocephalus: correlations with cortical 
Alzheimer's disease confirmed by pathologic analysis. AJNR American 
journal of neuroradiology 2000;21:409-414. 
 
89.Kondo M, Tokuda T, Itsukage M, et al. Distribution of amyloid burden 
differs between idiopathic normal pressure hydrocephalus and Alzheimer's 
disease. The neuroradiology journal 2013;26:41-46. 
 
90.Wikkelso C, Hellstrom P, Klinge PM, Tans JT. The European iNPH 
Multicentre Study on the predictive values of resistance to CSF outflow and 
the CSF Tap Test in patients with idiopathic normal pressure hydrocephalus. 
Journal of neurology, neurosurgery, and psychiatry 2013;84:562-568. 
 
91.Harrison's Neurology in Clinical Medicine, Second Edition ed: McGraw-Hill 
2010. 
 
92.Vanneste J, Augustijn P, Dirven C, Tan WF, Goedhart ZD. Shunting 
normal-pressure hydrocephalus: do the benefits outweigh the risks? A 
multicenter study and literature review. Neurology 1992;42:54-59. 
93.Trenkwalder C, Schwarz J, Gebhard J, et al. Starnberg trial on 
epidemiology of Parkinsonism and hypertension in the elderly. Prevalence of 
Parkinson's disease and related disorders assessed by a door-to-door survey 
of inhabitants older than 65 years. Archives of neurology 1995;52:1017-1022. 
Epidemiology of Normal Pressure Hydrocephalus 
94 
 
94.Brean A, Eide PK. Prevalence of probable idiopathic normal pressure 
hydrocephalus in a Norwegian population. Acta neurologica Scandinavica 
2008;118:48-53. 
 
95.Hiraoka K, Meguro K, Mori E. Prevalence of idiopathic normal-pressure 
hydrocephalus in the elderly population of a Japanese rural community. 
Neurologia medico-chirurgica 2008;48:197-199; discussion 199-200. 
 
96.Tanaka N, Yamaguchi S, Ishikawa H, Ishii H, Meguro K. Prevalence of 
possible idiopathic normal-pressure hydrocephalus in Japan: the Osaki-Tajiri 
project. Neuroepidemiology 2009;32:171-175. 
 
97.Iseki C, Kawanami T, Nagasawa H, et al. Asymptomatic ventriculomegaly 
with features of idiopathic normal pressure hydrocephalus on MRI (AVIM) in 
the elderly: a prospective study in a Japanese population. Journal of the 
neurological sciences 2009;277:54-57. 
 
98.Israelsson H, Birgander R, Ambarki K, Eklund A, Malm J. 
Ventriculomegaly and balance disturbances in patients with TIA. Acta 
neurologica Scandinavica 2012;125:163-170. 
 
99.Vale FA, Miranda SJ. Clinical and demographic features of patients with 
dementia attended in a tertiary outpatient clinic. Arquivos de neuro-psiquiatria 
2002;60:548-552. 
 
100.Marmarou A, Young HF, Aygok GA. Estimated incidence of normal 
pressure hydrocephalus and shunt outcome in patients residing in assisted-
living and extended-care facilities. Neurosurgical focus 2007;22:E1. 
 
101.Razay G, Wimmer M. Normal pressure hydrocephalus: Treatable 
dementia, missed diagnosis&#x2014;The Launceston Prevalence Study. 
Alzheimer's & Dementia: The Journal of the Alzheimer's Association;9:P755. 
 
102.Martin-Laez R, Caballero-Arzapalo H, Lopez-Menendez LA, Arango-
Lasprilla JC, Vazquez-Barquero A. Epidemiology of Idiopathic Normal 
Pressure Hydrocephalus: A Systematic Review of the Literature. World 
neurosurgery 2015;84:2002-2009. 
 
 95 
103.Iseki C, Takahashi Y, Wada M, Kawanami T, Adachi M, Kato T. 
Incidence of idiopathic normal pressure hydrocephalus (iNPH): a 10-year 
follow-up study of a rural community in Japan. Journal of the neurological 
sciences 2014;339:108-112. 
 
104.Tisell M, Hoglund M, Wikkelso C. National and regional incidence of 
surgery for adult hydrocephalus in Sweden. Acta neurologica Scandinavica 
2005;112:72-75. 
 
105.Brean A, Fredo HL, Sollid S, Muller T, Sundstrom T, Eide PK. Five-year 
incidence of surgery for idiopathic normal pressure hydrocephalus in Norway. 
Acta neurologica Scandinavica 2009;120:314-316. 
 
106.Mori E. DESH vs. Tap Test: The implications of DESH on clinical practive 
of NPH.  International Hydrocephalus Imaging Working Group; 2013; San 
Diego. 
 
107.Ishikawa M, Hashimoto M, Kuwana N, et al. Guidelines for management 
of idiopathic normal pressure hydrocephalus. Neurologia medico-chirurgica 
2008;48 Suppl:S1-23. 
 
108.Devito EE, Pickard JD, Salmond CH, Iddon JL, Loveday C, Sahakian BJ. 
The neuropsychology of normal pressure hydrocephalus (NPH). British 
journal of neurosurgery 2005;19:217-224. 
 
109.Dincer A, Kohan S, Ozek MM. Is all "communicating" hydrocephalus 
really communicating? Prospective study on the value of 3D-constructive 
interference in steady state sequence at 3T. AJNR American journal of 
neuroradiology 2009;30:1898-1906. 
 
110.Ziegelitz D, Starck G, Mikkelsen IK, et al. Absolute quantification of 
cerebral blood flow in neurologically normal volunteers: dynamic-susceptibility 
contrast MRI-perfusion compared with computed tomography (CT)-perfusion. 
Magnetic resonance in medicine 2009;62:56-65. 
111.Owler BK, Momjian S, Czosnyka Z, et al. Normal pressure 
hydrocephalus and cerebral blood flow: a PET study of baseline values. 
Journal of cerebral blood flow and metabolism : official journal of the 
International Society of Cerebral Blood Flow and Metabolism 2004;24:17-23. 
 
Epidemiology of Normal Pressure Hydrocephalus 
96 
112.Granado JM, Diaz F, Alday R. Evaluation of brain SPECT in the 
diagnosis and prognosis of the normal pressure hydrocephalus syndrome. 
Acta neurochirurgica 1991;112:88-91. 
 
113.Virhammar J, Laurell K, Ahlgren A, Cesarini KG, Larsson EM. Idiopathic 
normal pressure hydrocephalus: cerebral perfusion measured with pCASL 
before and repeatedly after CSF removal. Journal of cerebral blood flow and 
metabolism : official journal of the International Society of Cerebral Blood 
Flow and Metabolism 2014;34:1771-1778. 
 
114.Larsson A, Moonen M, Bergh AC, Lindberg S, Wikkelso C. Predictive 
value of quantitative cisternography in normal pressure hydrocephalus. Acta 
neurologica Scandinavica 1990;81:327-332. 
 
115.Kitagaki H, Mori E, Ishii K, Yamaji S, Hirono N, Imamura T. CSF spaces 
in idiopathic normal pressure hydrocephalus: morphology and volumetry. 
AJNR American journal of neuroradiology 1998;19:1277-1284. 
 
116.Akiguchi I, Shirakashi Y, Budka H, et al. Disproportionate subarachnoid 
space hydrocephalus-outcome and perivascular space. Annals of clinical and 
translational neurology 2014;1:562-569. 
 
117.Palm WM, Saczynski JS, van der Grond J, et al. Ventricular dilation: 
association with gait and cognition. Annals of neurology 2009;66:485-493. 
 
118.Kimberly HH, Shah S, Marill K, Noble V. Correlation of optic nerve 
sheath diameter with direct measurement of intracranial pressure. Academic 
emergency medicine : official journal of the Society for Academic Emergency 
Medicine 2008;15:201-204. 
 
119.Ishii K, Kanda T, Harada A, et al. Clinical impact of the callosal angle in 
the diagnosis of idiopathic normal pressure hydrocephalus. European 
radiology 2008;18:2678-2683. 
120.Gideon P, Stahlberg F, Thomsen C, Gjerris F, Sorensen PS, Henriksen 
O. Cerebrospinal fluid flow and production in patients with normal pressure 
hydrocephalus studied by MRI. Neuroradiology 1994;36:210-215. 
 
121.Krauss JK, Regel JP, Vach W, Jungling FD, Droste DW, Wakhloo AK. 
Flow void of cerebrospinal fluid in idiopathic normal pressure hydrocephalus 
 97 
of the elderly: can it predict outcome after shunting? Neurosurgery 
1997;40:67-73; discussion 73-64. 
 
122.Evans WA, Jr. An encephalographic ratio for estimating the size of the 
cerebral ventricles: Further experience with serial observations. American 
Journal of Diseases of Children 1942;64:820-830. 
 
123.Williams MA, Relkin NR. Diagnosis and management of idiopathic 
normal-pressure hydrocephalus. Neurology Clinical practice 2013;3:375-385. 
 
124.Synek V, Reuben JR, Du Boulay GH. Comparing Evans' index and 
computerized axial tomography in assessing relationship of ventricular size to 
brain size. Neurology 1976;26:231-233. 
 
125.Zatz LM. The Evans ratio for ventricular size: a calculation error. 
Neuroradiology 1979;18:81. 
 
126.Ambarki K, Israelsson H, Wahlin A, Birgander R, Eklund A, Malm J. 
Brain ventricular size in healthy elderly: comparison between Evans index 
and volume measurement. Neurosurgery 2010;67:94-99; discussion 99. 
 
127.Jacoby RJ, Levy R, Dawson JM. Computed tomography in the elderly: I. 
The normal population. The British journal of psychiatry : the journal of 
mental science 1980;136:249-255. 
 
128.Inatomi Y, Yonehara T, Hashimoto Y, Hirano T, Uchino M. Correlation 
between ventricular enlargement and white matter changes. Journal of the 
neurological sciences 2008;269:12-17. 
 
129.Toma AK, Holl E, Kitchen ND, Watkins LD. Evans' index revisited: the 
need for an alternative in normal pressure hydrocephalus. Neurosurgery 
2011;68:939-944. 
130.Moore DW, Kovanlikaya I, Heier LA, et al. A pilot study of quantitative 
MRI measurements of ventricular volume and cortical atrophy for the 
differential diagnosis of normal pressure hydrocephalus. Neurology research 
international 2012;2012:718150. 
 
131.Matsumae M, Kikinis R, Morocz I, et al. Intracranial compartment 
volumes in patients with enlarged ventricles assessed by magnetic 
Epidemiology of Normal Pressure Hydrocephalus 
98 
resonance-based image processing. Journal of neurosurgery 1996;84:972-
981. 
 
132.Palm WM, Walchenbach R, Bruinsma B, et al. Intracranial compartment 
volumes in normal pressure hydrocephalus: volumetric assessment versus 
outcome. AJNR American journal of neuroradiology 2006;27:76-79. 
 
133.Lenfeldt N, Hansson W, Larsson A, Birgander R, Eklund A, Malm J. 
Three-day CSF drainage barely reduces ventricular size in normal pressure 
hydrocephalus. Neurology 2012;79:237-242. 
 
134.Wikkelso C, Andersson H, Blomstrand C, Lindqvist G. The clinical effect 
of lumbar puncture in normal pressure hydrocephalus. Journal of neurology, 
neurosurgery, and psychiatry 1982;45:64-69. 
 
135.Mihalj M, Dolic K, Kolic K, Ledenko V. CSF tap test - Obsolete or 
appropriate test for predicting shunt responsiveness? A systemic review. 
Journal of the neurological sciences 2016;362:78-84. 
 
136.Bergsneider M, Black PM, Klinge P, Marmarou A, Relkin N. Surgical 
management of idiopathic normal-pressure hydrocephalus. Neurosurgery 
2005;57:S29-39; discussion ii-v. 
 
137.Patwardhan RV, Nanda A. Implanted ventricular shunts in the United 
States: the billion-dollar-a-year cost of hydrocephalus treatment. 
Neurosurgery 2005;56:139-144; discussion 144-135. 
 
138.Liu A, Sankey EW, Jusue-Torres I, et al. Clinical outcomes after 
ventriculoatrial shunting for idiopathic normal pressure hydrocephalus. 
Clinical neurology and neurosurgery 2016;143:34-38. 
139.Aoki N. Lumboperitoneal Shunt: Clinical Applications, Complications, and 
Comparison with Ventriculoperitoneal Shunt. Neurosurgery 1990;26:998-
1004. 
 
140.McCullough DC. A history of the treatment of hydrocephalus. Fetal 
therapy 1986;1:38-45. 
 
141.Halperin JJ, Kurlan R, Schwalb JM, Cusimano MD, Gronseth G, Gloss D. 
Practice guideline: Idiopathic normal pressure hydrocephalus: Response to 
 99 
shunting and predictors of response: Report of the Guideline Development, 
Dissemination, and Implementation Subcommittee of the American Academy 
of Neurology. Neurology 2015;85:2063-2071. 
 
142.Concato J, Shah N, Horwitz RI. Randomized, controlled trials, 
observational studies, and the hierarchy of research designs. The New 
England journal of medicine 2000;342:1887-1892. 
 
143.Benson K, Hartz AJ. A comparison of observational studies and 
randomized, controlled trials. The New England journal of medicine 
2000;342:1878-1886. 
 
144.Andren K, Wikkelso C, Tisell M, Hellstrom P. Natural course of idiopathic 
normal pressure hydrocephalus. Journal of neurology, neurosurgery, and 
psychiatry 2014;85:806-810. 
 
145.Rockers PC, Rottingen JA, Shemilt I, Tugwell P, Barnighausen T. 
Inclusion of quasi-experimental studies in systematic reviews of health 
systems research. Health policy (Amsterdam, Netherlands) 2015;119:511-
521. 
 
146.Shadish WR, Cook TD, Campbell DT. Experimental and Quasi-
experimental Designs for Generalized Causal Inference: Houghton Mifflin, 
2002. 
 
147.Toma AK, Papadopoulos MC, Stapleton S, Kitchen ND, Watkins LD. 
Systematic review of the outcome of shunt surgery in idiopathic normal-
pressure hydrocephalus. Acta neurochirurgica 2013;155:1977-1980. 
148.Hellstrom P, Edsbagge M, Blomsterwall E, et al. Neuropsychological 
effects of shunt treatment in idiopathic normal pressure hydrocephalus. 
Neurosurgery 2008;63:527-535; discussion 535-526. 
 
149.Thomas G, McGirt MJ, Woodworth G, et al. Baseline neuropsychological 
profile and cognitive response to cerebrospinal fluid shunting for idiopathic 
normal pressure hydrocephalus. Dementia and geriatric cognitive disorders 
2005;20:163-168. 
 
150.Peterson KA, Savulich G, Jackson D, Killikelly C, Pickard JD, Sahakian 
BJ. The effect of shunt surgery on neuropsychological performance in normal 
Epidemiology of Normal Pressure Hydrocephalus 
100 
pressure hydrocephalus: a systematic review and meta-analysis. Journal of 
neurology 2016. 
 
151.Klinge P, Hellstrom P, Tans J, Wikkelso C. One-year outcome in the 
European multicentre study on iNPH. Acta neurologica Scandinavica 
2012;126:145-153. 
 
152.van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. 
Interobserver agreement for the assessment of handicap in stroke patients. 
Stroke; a journal of cerebral circulation 1988;19:604-607. 
 
153.Hellstrom P, Klinge P, Tans J, Wikkelso C. A new scale for assessment 
of severity and outcome in iNPH. Acta neurologica Scandinavica 
2012;126:229-237. 
 
154.Kazui H, Miyajima M, Mori E, Ishikawa M. Lumboperitoneal shunt 
surgery for idiopathic normal pressure hydrocephalus (SINPHONI-2): an 
open-label randomised trial. The Lancet Neurology 2015. 
 
155.Miyajima M, Kazui H, Mori E, Ishikawa M. One-year outcome in patients 
with idiopathic normal-pressure hydrocephalus: comparison of 
lumboperitoneal shunt to ventriculoperitoneal shunt. Journal of neurosurgery 
2016:1-10. 
 
156.Boon AJ, Tans JT, Delwel EJ, et al. Dutch normal pressure 
hydrocephalus study: baseline characteristics with emphasis on clinical 
findings. European journal of neurology : the official journal of the European 
Federation of Neurological Societies 1997;4:39-47. 
157.Meier U. The grading of normal pressure hydrocephalus. 
Biomedizinische Technik Biomedical engineering 2002;47:54-58. 
 
158.Malm J, Kristensen B, Stegmayr B, Fagerlund M, Koskinen LO. Three-
year survival and functional outcome of patients with idiopathic adult 
hydrocephalus syndrome. Neurology 2000;55:576-578. 
 
159.Tisell M, Hellstrom P, Ahl-Borjesson G, et al. Long-term outcome in 109 
adult patients operated on for hydrocephalus. British journal of neurosurgery 
2006;20:214-221. 
 
 101 
160.Kahlon B, Sjunnesson J, Rehncrona S. Long-term outcome in patients 
with suspected normal pressure hydrocephalus. Neurosurgery 2007;60:327-
332; discussion 332. 
 
161.Savolainen S, Hurskainen H, Paljarvi L, Alafuzoff I, Vapalahti M. Five-
year outcome of normal pressure hydrocephalus with or without a shunt: 
predictive value of the clinical signs, neuropsychological evaluation and 
infusion test. Acta neurochirurgica 2002;144:515-523; discussion 523. 
 
162.Raftopoulos C, Massager N, Baleriaux D, Deleval J, Clarysse S, Brotchi 
J. Prospective analysis by computed tomography and long-term outcome of 
23 adult patients with chronic idiopathic hydrocephalus. Neurosurgery 
1996;38:51-59. 
 
163.Mirzayan MJ, Luetjens G, Borremans JJ, Regel JP, Krauss JK. Extended 
long-term (> 5 years) outcome of cerebrospinal fluid shunting in idiopathic 
normal pressure hydrocephalus. Neurosurgery 2010;67:295-301. 
 
164.Toma AK, Stapleton S, Papadopoulos MC, Kitchen ND, Watkins LD. 
Natural history of idiopathic normal-pressure hydrocephalus. Neurosurgical 
review 2011;34:433-439. 
 
165.Koivisto AM, Kurki MI, Alafuzoff I, et al. High Risk of Dementia in 
Ventricular Enlargement with Normal Pressure Hydrocephalus Related 
Symptoms1. Journal of Alzheimer's disease : JAD 2016. 
 
166.World Population Ageing 2013: United Nations, Department of Economic 
and Social Affairs, Population Division (2013), ST/ESA/SER.A/348. 
167.Wan H, Goodkind D, Kowal P. An Aging World: 2015. United States 
Census Bureau, 2016. 
 
168.Mathers CD, Stevens GA, Boerma T, White RA, Tobias MI. Causes of 
international increases in older age life expectancy. Lancet 2015;385:540-
548. 
 
169.Oeppen J, Vaupel JW. Demography. Broken limits to life expectancy. 
Science 2002;296:1029-1031. 
 
Epidemiology of Normal Pressure Hydrocephalus 
102 
170.Gruenberg EM. The failures of success. The Milbank Memorial Fund 
quarterly Health and society 1977;55:3-24. 
 
171.Bloom DE, Chatterji S, Kowal P, et al. Macroeconomic implications of 
population ageing and selected policy responses. Lancet 2015;385:649-657. 
 
172.Vaupel JW. Biodemography of human ageing. Nature 2010;464:536-542. 
 
173.Sousa RM, Ferri CP, Acosta D, et al. Contribution of chronic diseases to 
disability in elderly people in countries with low and middle incomes: a 10/66 
Dementia Research Group population-based survey. Lancet 2009;374:1821-
1830. 
 
174.Fratiglioni L, Launer LJ, Andersen K, et al. Incidence of dementia and 
major subtypes in Europe: A collaborative study of population-based cohorts. 
Neurologic Diseases in the Elderly Research Group. Neurology 2000;54:S10-
15. 
 
175.Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP. The global 
prevalence of dementia: a systematic review and metaanalysis. Alzheimer's 
& dementia : the journal of the Alzheimer's Association 2013;9:63-75.e62. 
 
176.Wimo A, Jonsson L, Bond J, Prince M, Winblad B. The worldwide 
economic impact of dementia 2010. Alzheimer's & dementia : the journal of 
the Alzheimer's Association 2013;9:1-11.e13. 
 
177.Prince MJ, Wu F, Guo Y, et al. The burden of disease in older people 
and implications for health policy and practice. Lancet 2015;385:549-562. 
 
178.Wu YT, Fratiglioni L, Matthews FE, et al. Dementia in western Europe: 
epidemiological evidence and implications for policy making. The Lancet 
Neurology 2016;15:116-124. 
 
179.Satizabal CL, Beiser AS, Chouraki V, Chene G, Dufouil C, Seshadri S. 
Incidence of Dementia over Three Decades in the Framingham Heart Study. 
The New England journal of medicine 2016;374:523-532. 
 
180.Ngandu T, Lehtisalo J, Solomon A, et al. A 2 year multidomain 
intervention of diet, exercise, cognitive training, and vascular risk monitoring 
 103 
versus control to prevent cognitive decline in at-risk elderly people (FINGER): 
a randomised controlled trial. Lancet 2015;385:2255-2263. 
 
181.Bengtsson C, Blohme G, Hallberg L, et al. The study of women in 
Gothenburg 1968-1969--a population study. General design, purpose and 
sampling results. Acta medica Scandinavica 1973;193:311-318. 
 
182.Palsson S, Larsson L, Tengelin E, et al. The prevalence of depression in 
relation to cerebral atrophy and cognitive performance in 70- and 74-year-old 
women in Gothenburg. The Women's Health Study. Psychological medicine 
2001;31:39-49. 
 
183.Skoog I, Nilsson L, Palmertz B, Andreasson LA, Svanborg A. A 
population-based study of dementia in 85-year-olds. The New England 
journal of medicine 1993;328:153-158. 
 
184.Skoog I. Psychiatric epidemiology of old age: the H70 study--the NAPE 
lecture 2003. Acta psychiatrica Scandinavica 2004;109:4-18. 
 
185.Skoog I, Olesen PJ, Blennow K, Palmertz B, Johnson SC, Bigler ED. 
Head size may modify the impact of white matter lesions on dementia. 
Neurobiology of aging 2012;33:1186-1193. 
 
186.Palsson S, Aevarsson O, Skoog I. Depression, cerebral atrophy, 
cognitive performance and incidence of dementia. Population study of 85-
year-olds. The British journal of psychiatry : the journal of mental science 
1999;174:249-253. 
 
187.Dey DK, Bosaeus I, Lissner L, Steen B. Changes in body composition 
and its relation to muscle strength in 75-year-old men and women: a 5-year 
prospective follow-up study of the NORA cohort in Goteborg, Sweden. 
Nutrition (Burbank, Los Angeles County, Calif) 2009;25:613-619. 
 
188.Evans Wa JR. An encephalographic ratio for estimating the size of the 
cerebral ventricles: Further experience with serial observations. American 
Journal of Diseases of Children 1942;64:820-830. 
 
Epidemiology of Normal Pressure Hydrocephalus 
104 
189.Ludvigsson JF, Andersson E, Ekbom A, et al. External review and 
validation of the Swedish national inpatient register. BMC public health 
2011;11:450. 
 
190.R: A language and environment for statistical computing [computer 
program] R Foundation for Statistical Computing, 2014. 
 
191.National Board of Health and Welfare's Cause of Death Register [online]. 
Available at: 
http://www.socialstyrelsen.se/statistics/statisticaldatabase/help/causeofdeath. 
Accessed 2015-11-21. 
 
192.Lopez OL, Becker JT, Jungreis CA, et al. Computed tomography--but not 
magnetic resonance imaging--identified periventricular white-matter lesions 
predict symptomatic cerebrovascular disease in probable Alzheimer's 
disease. Archives of neurology 1995;52:659-664. 
  
